Bjornstad Syndrome

Bjornstad syndrome is a predominantly hair-and-hearing presentation of autosomal recessive BCS1L-related mitochondrial disease, characterized by pili torti, hair fragility and sensorineural hearing loss. Onset and hearing severity vary. BCS1L assists delivery of the folded Rieske iron-sulfur protein to respiratory complex III; pathogenic genotypes can impair assembly and alter cellular redox metabolism. The mechanisms determining cochlear and follicular vulnerability remain incompletely established. Most recognized cases have a restricted phenotype, but additional findings, including intellectual disability, have been reported. Severe multisystem BCS1L disorders overlap genetically and require a broader clinical assessment.

Ask OpenScientist

Ask a research question about Bjornstad Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
6
Pathophys.
6
Phenotypes
1
Hypotheses
3
Gaps
19
Pathograph
1
Genes
4
Variants
5
Medical Actions
6
Differentials
18
References
1
Deep Research
🏷

Classifications

Mechanistic Nosology
mitochondrial disease
👪

Inheritance

1
Autosomal recessive inheritance HP:0000007
Molecularly established BCS1L-related Bjornstad syndrome is autosomal recessive. Both homozygous and compound-heterozygous genotypes occur, including a reported missense/nonsense combination. Protein residual function and clinical severity cannot be inferred solely from the variant class. Historical apparently dominant pedigrees predated identification of BCS1L and do not establish dominant BCS1L inheritance.
Autosomal recessive inheritance Penetrance: UNKNOWN Expressivity: VARIABLE
Show evidence (4 references)
PMID:17314340 SUPPORT DIRECT BACKGROUND Human Clinical
"The Björnstad syndrome, an autosomal recessive disorder associated with sensorineural hearing loss and pili torti, is caused by mutation of a previously unidentified gene on chromosome 2q34-36."
States the recessive mode of inheritance and the two defining clinical features together.
PMID:24172246 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"A novel homozygous missense mutation c.901T>A was identified, which segregated with the disease in the family."
Homozygosity for a missense allele segregating with disease in a large consanguineous family is direct evidence of recessive transmission.
PMID:25895478 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"The siblings were compound heterozygotes, and the inheritance mode of autosomal recessive was postulated."
The molecular report documents a compound-heterozygous family.
+ 1 more reference
◈

Mechanistic Hypotheses

1
Preferential oxidative injury in cochlear and follicular tissues
ROS_TISSUE_VULNERABILITY EMERGING
Evidence balance 1 support
Cellular ROS abnormalities and the predominantly hair-and-hearing phenotype support a proposed oxidative-vulnerability model. Direct measurement and rescue in the affected tissues are needed to establish these causal links; occasional additional clinical findings and cochlear malformations are not explained by the model.
Show evidence (1 reference)
PMID:17314340 SUPPORT INDIRECT PRIMARY RESULT Other
"Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues to mitochondrial function, particularly to the production of reactive oxygen species."
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct tissue-specific oxidative-injury experiment.
?

Discussions and Knowledge Gaps

3
Why do many BCS1L genotypes preferentially affect hearing and hair, while other genotypes cause broader organ disease?
KNOWLEDGE GAP bjornstad_tissue_restriction
Increased cellular ROS and a mitochondrial-content difference were observed in the original mutant comparison, but neither establishes why particular tissues are affected. The reviewed sources do not provide allele-matched cochlear and follicular measurements. Additional clinical manifestations can occur, so tissue restriction is relative. Comparable oxidative burden can have different consequences because tissues differ in repair, antioxidant capacity and energy demand.
Proposed experiments
Allele-matched tissue comparison of oxidative burden
bjornstad_allele_matched_tissue_ros
Compare matched biallelic Bjornstad and severe BCS1L genotypes in isogenic human iPSC-derived inner-ear, hair-follicle and hepatic models. Measure complex III assembly, respiration, ROS, cell survival and follicular organization, and add genetic correction plus independently verified ROS-lowering interventions.
Supporting outcome
  • Cochlear and follicular dysfunction tracks with oxidative injury and improves when ROS is normalized, with effects distinguished from restoration of respiration.
Refuting outcome
  • Cochlear and follicular injury persists despite sustained normalization of ROS with multiple validated interventions, while BCS1L correction rescues the phenotype; this would argue against ROS as the principal mediator.
Show evidence (1 reference)
PMID:17314340 SUPPORT INDIRECT PRIMARY RESULT Other
"Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues to mitochondrial function, particularly to the production of reactive oxygen species."
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct tissue-specific oxidative-injury experiment.
Which experimental systems can reproduce the hair and hearing phenotype for clinically matched BCS1L genotypes?
HUMAN MODEL MISMATCH bjornstad_no_faithful_model
The reviewed patient-cell, yeast, HeLa and purified-protein systems resolve assembly or substrate interactions but do not reproduce a cochlea and hair follicle together. Severe BCS1L animal models cannot automatically validate a predominantly hair-and-hearing mechanism. A disease-matched tissue model remains a gap in this evidence set; this is not an exhaustive claim that no relevant model exists.
Show evidence (2 references)
PMID:40660675 SUPPORT DIRECT PRIMARY RESULT In Vitro
"Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1, similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure 3G)."
The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association, not ATPase turnover or translocation rate.
PMID:38821922 SUPPORT INDIRECT PRIMARY RESULT In Vitro
"Our results show that Bcs1L transitions directly between the ATP and ADP conformations, with no indication of the existence of additional intermediate forms, supporting a concerted mechanism."
Purified wild-type mouse Bcs1L with a bovine Rieske extrinsic-domain substrate informs normal transport architecture. It does not establish the molecular defect of a human Bjornstad allele.
Which biochemical steps distinguish individual Bjornstad genotypes from other BCS1L presentations?
KNOWLEDGE GAP bjornstad_variant_mechanisms
The 2007 residue-interface versus ATP-site classification was a homology-based explanation of the alleles studied then. New wild-type structural work and residual Rieske binding by p.Arg183His refine the model but do not prove normal ATP turnover for every Bjornstad variant. Reported compound genotypes can pair alleles associated with different clinical spectra, including a missense/nonsense combination. Assays of the complete genotype and multiple steps in transport are needed.
Show evidence (3 references)
PMID:17314340 SUPPORT DIRECT PRIMARY RESULT Computational
"Patients with the Björnstad syndrome have mutations that alter residues involved in protein-protein interactions, whereas mutations in patients with complex III deficiency alter ATP-binding residues, as deduced from the crystal structure of a related AAA-family ATPase."
The residue-role assignments are computational deductions for the original mutant set, not a universal clinical classification.
PMID:40660675 SUPPORT DIRECT PRIMARY RESULT In Vitro
"Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1, similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure 3G)."
The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association, not ATPase turnover or translocation rate.
PMID:39053894 SUPPORT INDIRECT REVIEW SYNTHESIS Other
"However, despite these developments, the molecular pathological mechanisms underlying the clinical heterogeneity in different cases of mitochondrial cIII deficiency are still not fully comprehended."
The review describes unresolved clinical heterogeneity across complex III disorders, providing broader context rather than allele-specific experimental proof.
⚙

Pathophysiology

6
BCS1L Rieske Protein Insertion Failure
BCS1L is an inner-mitochondrial-membrane AAA ATPase that delivers the folded Rieske iron-sulfur protein, UQCRFS1, during complex III maturation. Disease-associated genotypes impair this assembly function to varying degrees. A Bjornstad-associated p.Arg183His protein retained partial UQCRFS1 binding in a HeLa-cell co-immunoprecipitation assay. This supports impaired substrate engagement for that allele but does not directly measure insertion kinetics. Neither normal ATP turnover nor an identical substrate-binding lesion has been established for every Bjornstad genotype.
BCS1L hgnc:1020 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves BCS1L (hgnc:1020). hgnc:1020 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context BCS1L hgnc:1020 HUGO Gene Nomenclature Committee (hgnc) Relation: this genetic context concerns this gene This genetic context concerns BCS1L (hgnc:1020). hgnc:1020 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: GERMLINE functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
Biallelic pathogenic genotypes with variable residual BCS1L function; both homozygous and compound-heterozygous states are reported, including a missense/nonsense pair. The molecular effect depends on the complete genotype and cannot be assigned from variant class alone.
insertion of the Rieske iron-sulfur protein into the inner membrane GO:0045039 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased insertion of the Rieske iron-sulfur protein into the inner membrane, annotated with protein insertion into mitochondrial inner membrane (GO:0045039). GO:0045039 is a biological process from the Gene Ontology. ↓ DECREASED
BCS1L-mediated translocation of folded Rieske protein GO:0008320 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves BCS1L-mediated translocation of folded Rieske protein, annotated with transmembrane protein transporter activity (GO:0008320). GO:0008320 is a molecular function from the Gene Ontology.
Show evidence (2 references)
PMID:40660675 SUPPORT DIRECT PRIMARY RESULT In Vitro
"Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1, similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure 3G)."
The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association, not ATPase turnover or translocation rate.
PMID:38821922 SUPPORT INDIRECT PRIMARY RESULT In Vitro
"Our results show that Bcs1L transitions directly between the ATP and ADP conformations, with no indication of the existence of additional intermediate forms, supporting a concerted mechanism."
Purified wild-type mouse Bcs1L with a bovine Rieske extrinsic-domain substrate informs normal transport architecture. It does not establish the molecular defect of a human Bjornstad allele.
Complex III Assembly Defect
BCS1L dysfunction compromises maturation of Rieske-containing complex III and respiratory supercomplex organization. The extent of the assembly abnormality depends on the genotype and assay system; complete absence of mature complex III is not established across Bjornstad cases.
mitochondrial respiratory chain complex III assembly GO:0034551 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased mitochondrial respiratory chain complex III assembly (GO:0034551). GO:0034551 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:17314340 SUPPORT DIRECT PRIMARY RESULT In Vitro
"All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial electron-transport chain, and increased the production of reactive oxygen species."
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
Reduced respiratory electron transfer
Reduced mitochondrial electron-transfer activity was measured in the original functional study of BCS1L mutants. This is a biochemical consequence distinct from the assembly defect and is not a claim that every patient has abnormal muscle respiratory-enzyme testing.
respiratory electron transport chain GO:0022904 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased respiratory electron transport chain (GO:0022904). GO:0022904 is a biological process from the Gene Ontology. ↓ DECREASED
Show evidence (1 reference)
PMID:17314340 SUPPORT DIRECT PRIMARY RESULT In Vitro
"All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial electron-transport chain, and increased the production of reactive oxygen species."
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
Excess Reactive Oxygen Species Production
The original functional study found increased cellular reactive oxygen species for its tested BCS1L mutants. Only the severe complex-III-deficiency mutant group also showed increased mitochondrial content in that comparison. These results support disturbed cellular redox metabolism but do not identify incompletely assembled complex III as the source of increased superoxide or establish a universal quantitative severity rule. Selective tissue injury is a further hypothesis.
reactive oxygen species metabolic process GO:0072593 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased reactive oxygen species metabolic process (GO:0072593). GO:0072593 is a biological process from the Gene Ontology. ↑ INCREASED
Show evidence (2 references)
PMID:17314340 SUPPORT DIRECT PRIMARY RESULT In Vitro
"All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial electron-transport chain, and increased the production of reactive oxygen species."
The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
PMID:17314340 SUPPORT DIRECT PRIMARY RESULT In Vitro
"However, only mutations associated with complex III deficiency increased mitochondrial content, which further increased the production of reactive oxygen species."
The measured mitochondrial-content difference applies to the groups tested in this study; it does not by itself explain all tissue selectivity or all later genotypes.
Cochlear Oxidative Injury
Oxidative injury is a proposed connection between disturbed mitochondrial function and the cochlear hearing phenotype. The reviewed studies do not directly demonstrate elevated ROS or hair-cell death in Bjornstad cochlear tissue. The annotated hair-cell types are candidate affected cells, not a reported histological finding. Relative vulnerability, energy supply and structural cochlear abnormalities require separate evaluation; a specific defect in potassium recycling is not established.
cochlear inner hair cell CL:0000589 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear inner hair cell (CL:0000589). CL:0000589 is a cell type from the Cell Ontology. cochlear outer hair cell CL:0000601 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear outer hair cell (CL:0000601). CL:0000601 is a cell type from the Cell Ontology.
response to oxidative stress GO:0006979 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal response to oxidative stress (GO:0006979). GO:0006979 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Show evidence (1 reference)
PMID:17314340 SUPPORT INDIRECT PRIMARY RESULT Other
"Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues to mitochondrial function, particularly to the production of reactive oxygen species."
This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct tissue-specific oxidative-injury experiment.
Hair Shaft Keratin Assembly Failure
Transmission electron microscopy in one Bjornstad patient showed wavy cuticle layers of variable thickness and loosely packed cortical keratin intermediate filaments. The authors localized the abnormalities below the infundibulum and proposed abnormal disulfide bonding; they did not directly measure a disulfide-bond defect or establish ROS as its cause. Ex vivo hair testing found reduced mechanical strength, consistent with the fragile, twisted shaft phenotype.
hair follicular keratinocyte CL:2000092 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves hair follicular keratinocyte (CL:2000092). CL:2000092 is a cell type from the Cell Ontology.
Show evidence (2 references)
PMID:27882597 SUPPORT DIRECT PRIMARY RESULT In Vitro
"Additionally, the cortex in the samples showed loose keratin intermediate filaments (IF)."
Reports the ultrastructural cortical abnormality underlying the fragile shaft in a Bjornstad patient's hair.
PMID:27882597 SUPPORT DIRECT PRIMARY RESULT In Vitro
"Our results suggested that these abnormalities in pili torti had already occurred below the infundibulum."
Places the lesion inside the follicle during keratinization rather than in the emerged shaft, which is what makes it a follicular rather than a cosmetic problem.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Bjornstad Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

6
Ear 2
Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sensorineural hearing impairment (HP:0000407), qualified as childhood onset. HP:0000407 is a phenotype from the Human Phenotype Ontology.
Onset: CHILDHOOD
A defining component of the conventional clinical diagnosis; available selected reports do not establish population penetrance or a quantitative frequency band.
Show evidence (3 references)
PMID:24172246 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"In addition the patients had a moderate-to-severe degree of hearing impairment."
Documents the severity range of the hearing loss in all five affected members of one family.
PMID:30582773 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"Disease phenotypes are varied and can be as mild as Björnstad syndrome, characterized by pili torti and sensorineural hearing loss, or as severe as GRACILE syndrome, characterized by growth restriction, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death."
A review of all published BCS1L patients confirms sensorineural hearing loss as one of the two defining Bjornstad features.
PMID:32395403 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"with progressive sensori‐neural hearing loss noted from age 18 months onwards."
The individual case supports possible progression and early onset, not a universal course.
Incomplete partition of the cochlea type I HP:0011374 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Incomplete partition of the cochlea type I (HP:0011374), qualified as laterality bilateral. HP:0011374 is a phenotype from the Human Phenotype Ontology.
Laterality: BILATERAL
The evidence is one ascertained family. Its association with BCS1L disease and developmental mechanism remain uncertain, so no specific causal path is assigned.
Show evidence (1 reference)
PMID:37816838 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"Cochlear implant surgeries of two siblings (four ears) with profound SNHL and bilateral inner ear anomaly (incomplete partition type 1) were performed without complications."
Documents the malformation in both affected siblings, bilaterally, on preoperative assessment.
Head and Neck 1
Sparse scalp hair HP:0002209 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sparse scalp hair (HP:0002209). HP:0002209 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:32395403 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"with very sparse and brittle hair since birth"
This directly documents reduced scalp hair density in the reported patient.
Integument 2
Pili torti HP:0003777 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pili torti (HP:0003777). HP:0003777 is a phenotype from the Human Phenotype Ontology.
A defining component of the conventional clinical diagnosis; available selected reports do not establish population penetrance or a quantitative frequency band.
Show evidence (2 references)
PMID:28322498 SUPPORT DIRECT BACKGROUND Human Clinical
"Bjornstad syndrome is a rare condition characterized by pili torti and sensorineural hearing loss associated with pathological variations in BCS1L."
The introduction identifies pili torti as a conventional defining feature; it does not estimate its population frequency.
PMID:24172246 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"The hair fibers of all the patients were twisted around their axis and devoid of any pigment."
Five affected members of one family, all with twisted hair fibers, documenting the phenotype within a single kindred.
Brittle hair HP:0002299 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Brittle hair (HP:0002299). HP:0002299 is a phenotype from the Human Phenotype Ontology.
Hair fragility is documented clinically and by ex vivo mechanical testing; no population frequency is assigned.
Show evidence (1 reference)
PMID:32395403 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"with very sparse and brittle hair since birth"
Records sparse, brittle hair present from birth in a genetically confirmed patient.
Nervous System 1
Intellectual disability HP:0001249 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Intellectual disability (HP:0001249). HP:0001249 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"Developmental assessment showed intellectual disability."
The case report directly records this additional manifestation; it does not justify attributing every developmental difficulty solely to hearing loss.
🧬

Genetic Associations

1
BCS1L
Gene: BCS1L hgnc:1020 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is BCS1L (hgnc:1020). hgnc:1020 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (2 references)
PMID:17314340 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"Refined genetic mapping and DNA sequencing of 44 genes between D2S2210 and D2S2244 revealed BCS1L mutations."
The gene-identification study that established BCS1L as the Bjornstad syndrome locus.
PMID:24172246 SUPPORT DIRECT PRIMARY RESULT Computational
"This mutation results in the amino acid change p.Tyr301Asn and was predicted to be pathogenic by bioinformatics tools."
The amino-acid change is reported, but the quoted pathogenicity assessment is computational prediction, not a biochemical assay.
Variants (4)
NM_001079866.1:c.901T>A (p.Tyr301Asn)
MISSENSE
Homozygous AAA-domain missense allele segregating with Bjornstad syndrome in a large consanguineous Pakistani family with five affected individuals.
Show evidence (1 reference)
PMID:24172246 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"A novel homozygous missense mutation c.901T>A was identified, which segregated with the disease in the family."
Homozygosity for a missense allele segregating with disease in a large consanguineous family is direct evidence of recessive transmission.
p.Arg306Cys / p.Arg186Ter, as reported
Compound missense/nonsense genotype reported in two siblings diagnosed with Bjornstad syndrome; this disproves restriction to pairs of missense variants.
Show evidence (1 reference)
PMID:25895478 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"By analysis of exome of the proband, we identified a novel missense (p.R306C) mutation and a nonsense (p.R186*) mutation in the BCS1L gene."
Both variant classes were identified and subsequently confirmed by Sanger sequencing in the report.
c.232A>G (p.Ser78Gly) / c.794G>A (p.Arg265Gln), NM_001079866.2
Compound genotype in the diet case report. The Ser78Gly allele is also associated with severe disease in other genotypic contexts; its presence alone does not determine the phenotype.
Show evidence (1 reference)
PMID:32395403 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"We report on a 7‐year‐old female (BCS1L, NM_001079866.2, c.232A>G; p.Ser78Gly, c.794G>A; p.Arg265Gln)"
The source supplies the transcript and both alleles of the reported genotype.
c.649G>C (p.Asp217His) / c.671G>A (p.Arg224His), as reported
Two missense variants segregated from opposite unaffected parents in the 2021 case. Their specific biochemical effects were hypothesized rather than measured.
Show evidence (1 reference)
"Further investigation revealed that the patient's unaffected mother carried the heterozygous variant in exon 4 (c.649G >C; p. Asp217His), while his unaffected father had the heterozygous variant in exon 5 (c.671G >A; p. Arg224His)."
The full report documents parental segregation, with maternal Asp217His and paternal Arg224His; neither parent had the hair/hearing phenotype.
💊

Medical Actions

5
Cochlear implantation for profound hearing loss
Action: cochlear implant placementNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear implant placement, annotated with Surgical Procedure (NCIT:C15329), qualified as medical device cochlear implant. NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Surgery
Bilateral cochlear implantation was reported in two siblings with profound sensorineural hearing loss unresponsive to conventional hearing aids. Surgery was completed without observed complications and postoperative audiometry improved. The small family report supports considering implantation under usual candidacy assessment, not a syndrome-wide safety or efficacy estimate.
Target Phenotypes: Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:37816838 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"A retrospective report of two siblings with Bjornstad syndrome suffering profound SNHL unresponsive to conventional hearing aids treated with bilateral simultaneous cochlear implantation."
Documents the small retrospective family report and its indication.
PMID:37816838 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"Postoperative audiometric measurements showed a significiant improvement in pure-tone threshold and a word recognition score."
The two-sibling report documents improvement; it does not establish a population-level efficacy estimate.
Modified Atkins (mild ketogenic) diet
Action: mild ketogenic (modified Atkins) dietNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is mild ketogenic (modified Atkins) diet, annotated with Dietary Intervention (NCIT:C15447). NCIT:C15447 is a clinical intervention from the NCI Thesaurus. Ontology label: Dietary Intervention NCIT:C15447
Platform: Behavioral / lifestyle
A modified Atkins diet was used for four months in one seven-year-old with a reported Bjornstad genotype. Hair growth improved and was lost again after the diet stopped; hearing did not improve. There was no control group or measured correction of oxidative stress. Aminoaciduria was neither confirmed nor excluded, leaving a potential additional contributor to hair loss.
Mechanism Target:
Excess Reactive Oxygen Species Production — Reduced oxidative stress is a proposed rationale from general ketogenic-diet literature; the patient report did not measure this mechanism.
Show evidence (1 reference)
PMID:32395403 SUPPORT INDIRECT BACKGROUND Other
"Ketogenic diets stimulate mitochondrial biogenesis, improve mitochondrial function and decrease oxidative stress"
States the proposed mechanism of action against the oxidative-stress node; the inference from general ketogenic-diet biology to this disorder is not itself tested, hence INDIRECT.
Show evidence (3 references)
PMID:32395403 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"There was improved hair growth during MAD in this individual with BCS1l related mitochondrial disease"
The primary observation, stated by the authors with the hedging their single-patient design requires.
PMID:32395403 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"Figure 1F shows that the hair was lost again 6 months after cessation of MAD."
Withdrawal and relapse in the same patient is the strongest element of this report, though it remains a single uncontrolled observation.
PMID:32395403 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"A 3‐day dietary history indicated an adequate diet with no protein deficiency but aminoaciduria, as a possible contributing cause for alopecia, was not confirmed or excluded."
The report identifies a possible confounder of the hair response.
Genetic counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Platform: Behavioral / lifestyle
For two confirmed heterozygous carrier parents, each pregnancy has a Mendelian 25% probability of a child with the biallelic genotype. Counseling should use the familial variants and clinical spectrum, and explain that outcomes cannot be predicted from one allele alone.
Show evidence (1 reference)
PMID:17314340 SUPPORT DIRECT BACKGROUND Human Clinical
"The Björnstad syndrome, an autosomal recessive disorder associated with sensorineural hearing loss and pili torti, is caused by mutation of a previously unidentified gene on chromosome 2q34-36."
The recessive inheritance that determines the recurrence risk discussed in counseling.
Hearing aids and audiologic follow-up
Action: hearing-aid rehabilitationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is hearing-aid rehabilitation, annotated with Rehabilitation (NCIT:C15315). NCIT:C15315 is a clinical intervention from the NCI Thesaurus. Ontology label: Rehabilitation NCIT:C15315
Platform: Device
Hearing aids and ongoing audiologic assessment are used for the hearing phenotype. Benefit and need for implantation depend on individual hearing severity and response.
Target Phenotypes: Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
"had begun wearing hearing aids at the age of 4 years."
The case documents audiologic follow-up and hearing-aid use, without quantifying benefit.
Gentle hair care
Platform: Behavioral / lifestyle
Avoiding excessive grooming, heat, chemical treatment and mechanical trauma can reduce damage to fragile hair. This is general pili-torti care, not evidence that BCS1L function is restored.
Target Phenotypes: Brittle hair HP:0002299 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Brittle hair (HP:0002299). HP:0002299 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:34501349 SUPPORT INDIRECT REVIEW SYNTHESIS Human Clinical
"There is no specific treatment of pili torti. The avoidance of trauma to the hair is recommended."
The review supports general supportive care for hair fragility.
🔬

Diagnosis

3
Hair-shaft microscopy
Microscopic assessment identifies flattened and twisted hair shafts; electron microscopy documented these changes in the cited case. Hair findings need interpretation with audiology and molecular testing because pili torti occurs in multiple inherited and acquired conditions.
Show evidence (1 reference)
"Electron microscopy of hairs revealed flattening and twisting around the long axis."
Directly documents diagnostic hair microscopy.
BCS1L sequencing
BCS1L sequencing with parental segregation can confirm a compatible recessive genotype; exome or broader hearing-loss testing can help in atypical presentations. Normal muscle respiratory-chain enzyme activities do not exclude BCS1L disease: this limitation was observed in intermediate and severe cases, rather than demonstrated to be specific to classic Bjornstad syndrome.
Show evidence (2 references)
PMID:31435670 SUPPORT INDIRECT PRIMARY RESULT Human Clinical
"biochemical analysis of Complex III revealed normal respiratory chain enzyme activities in the muscle of both patients"
The two tested patients had intermediate multisystem disease and GRACILE syndrome. Their normal muscle enzyme assays establish a broader diagnostic limitation, not a finding unique to mild Bjornstad disease.
PMID:25895478 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"Our study extends the phenotypic spectrum of Björnstad syndrome and highlights the clinical applicability of exome sequencing as a diagnostic tool for atypical Mendelian disorders."
The report supports molecular investigation of atypical hearing and hair presentations.
Audiologic assessment and inner-ear imaging
Audiologic testing defines hearing severity and response to hearing aids. Imaging is important during cochlear-implant assessment because bilateral incomplete partition type I occurred in the reported implanted siblings.
Show evidence (1 reference)
PMID:37816838 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"Cochlear implant surgeries of two siblings (four ears) with profound SNHL and bilateral inner ear anomaly (incomplete partition type 1) were performed without complications."
Documents the malformation in both affected siblings, bilaterally, on preoperative assessment.
📊

Prevalence

1
Worldwide
Cases In Literature Unknown
Population prevalence is unknown. Published families and case reports do not supply a population denominator; clinical ascertainment and molecular confirmation vary.
Show evidence (1 reference)
PMID:24172246 SUPPORT DIRECT BACKGROUND Human Clinical
"Only few large families have been reported worldwide."
Describes sparse published pedigrees without quantifying population prevalence.
🔀

Differential Diagnoses

6

Conditions with similar clinical presentations that must be differentiated from Bjornstad Syndrome:

GRACILE syndrome
Overlapping Features A severe allelic BCS1L disorder with fetal growth restriction, aminoaciduria, cholestasis, iron overload, lactic acidosis and early death. Clinical severity and organ involvement depend on the complete genotype; a single residue-class rule does not reliably distinguish the syndromes.
Show evidence (1 reference)
PMID:17314340 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"BCS1L mutations cause disease phenotypes ranging from highly restricted pili torti and sensorineural hearing loss (the Björnstad syndrome) to profound multisystem organ failure (complex III deficiency and the GRACILE syndrome)."
States the allelic relationship and the clinical distance between the two ends of the BCS1L spectrum.
BCS1L Mitopathies (intermediate phenotypes)
Overlapping Features A proposed name for intermediate BCS1L phenotypes with variable renal, hepatic, neurologic and growth manifestations. Published labels overlap; assessment should characterize the organ findings and complete genotype rather than rely on the syndrome name alone.
Show evidence (1 reference)
PMID:30582773 SUPPORT DIRECT PRIMARY RESULT Human Clinical
"We propose a change in nomenclature that unifies the intermediate phenotype under "BCS1L Mitopathies"."
Records the proposed intermediate category so that entries between the two poles are not forced into the Bjornstad label.
Overlapping Features An X-linked copper transport disorder (ATP7A) that also produces pili torti, but with progressive neurodegeneration, seizures, hypotonia and connective tissue laxity from infancy, and with low serum copper and ceruloplasmin. Considered because pili torti on hair microscopy is the shared finding.
Show evidence (1 reference)
PMID:34501349 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"In patients with Menkes disease, neurodegenerative signs, including seizures, feeding difficulties, hypotonia, and psychomotor retardation usually occur at 2–3 months of age [5]."
The review contrasts early neurologic disease with the predominantly hair-and-hearing presentation.
Overlapping Features An X-linked disorder characterized by follicular atrophoderma, hypotrichosis, milia and early basal cell carcinomas. Pili torti may overlap, while the cutaneous tumour predisposition and follicular atrophoderma distinguish its usual presentation.
Show evidence (1 reference)
PMID:34501349 SUPPORT DIRECT REVIEW SYNTHESIS Human Clinical
"Bazex-Dupré-Christol syndrome is an X-linked semidominant disorder characterized by follicular atrophoderma, multiple milia, hypotrichosis, hypohidrosis, and an early development of basal cell carcinomas [54,55]."
The review supplies the distinguishing cutaneous phenotype. Its gene attribution is not adopted here.
Crandall syndrome
Overlapping Features Pili torti and sensorineural hearing loss can overlap, while hypogonadism distinguishes the reported Crandall phenotype.
Show evidence (1 reference)
"While pili torti and sensorineural hearing loss have been described in both Bjornstad syndrome and Crandall's syndrome, the latter is differentiated by hypogonadism."
The discussion identifies the shared features and clinical distinction.
{ }

Source YAML

click to show
name: Bjornstad Syndrome
creation_date: "2026-09-03T00:00:00Z"
category: Mendelian
disease_term:
  preferred_term: Bjornstad syndrome
  term:
    id: MONDO:0009872
    label: Bjornstad syndrome
synonyms:
- Bjornstad syndrome
- Björnstad syndrome
- pili torti and nerve deafness
- pili torti-sensorineural hearing loss
- deafness and pili torti, Bjornstad type
- BJS
classifications:
  mechanistic_category:
  - classification_value: mitochondrial disease
    notes: >-
      BCS1L is a nuclear-encoded mitochondrial assembly factor. Predominantly hair and hearing manifestations
      do not make this an mtDNA-inherited disorder.
    evidence:
    - reference: PMID:17314340
      reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        BCS1L encodes a member of the AAA family of ATPases that is necessary for
        the assembly of complex III in the mitochondria.
      explanation: >-
        Identifies the causal gene as a mitochondrial respiratory chain assembly
        factor, which is what places this disorder in the mitochondrial category.
      quote_role: BACKGROUND
      directness: DIRECT
description: >-
  Bjornstad syndrome is a predominantly hair-and-hearing presentation of autosomal recessive BCS1L-related
  mitochondrial disease, characterized by pili torti, hair fragility and sensorineural hearing loss. Onset
  and hearing severity vary. BCS1L assists delivery of the folded Rieske iron-sulfur protein to respiratory
  complex III; pathogenic genotypes can impair assembly and alter cellular redox metabolism. The mechanisms
  determining cochlear and follicular vulnerability remain incompletely established. Most recognized cases
  have a restricted phenotype, but additional findings, including intellectual disability, have been reported.
  Severe multisystem BCS1L disorders overlap genetically and require a broader clinical assessment.
notes: >-
  This entry centers on the pili-torti and hearing-loss phenotype, while distinguishing severe multisystem
  BCS1L disease in the differential diagnosis. Published diagnostic labels overlap; an additional finding does
  not by itself establish a separate molecular disorder. Gene and variant effects depend on the complete biallelic
  genotype, and published protein numbering is retained as reported. The institutional PDF from the University
  of Medicine and Pharmacy at Ho Chi Minh City is the full text of PMID:34931354, whose PubMed record lacks
  an abstract. PMID:41466500 (late-onset alopecia) and PMID:41814923 (tofacitinib/minoxidil) are recent bibliographic
  leads; the retrieved records contained no abstract and full text was not obtained, so no patient details
  or treatment-response claims are derived from their titles.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  expressivity: VARIABLE
  penetrance: UNKNOWN
  description: >-
    Molecularly established BCS1L-related Bjornstad syndrome is autosomal recessive. Both homozygous and compound-heterozygous
    genotypes occur, including a reported missense/nonsense combination. Protein residual function and clinical
    severity cannot be inferred solely from the variant class. Historical apparently dominant pedigrees predated
    identification of BCS1L and do not establish dominant BCS1L inheritance.
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Björnstad syndrome, an autosomal recessive disorder associated with
      sensorineural hearing loss and pili torti, is caused by mutation of a
      previously unidentified gene on chromosome 2q34-36.
    explanation: >-
      States the recessive mode of inheritance and the two defining clinical
      features together.
    quote_role: BACKGROUND
    directness: DIRECT
  - reference: PMID:24172246
    reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A novel homozygous missense mutation c.901T>A was identified, which
      segregated with the disease in the family.
    explanation: >-
      Homozygosity for a missense allele segregating with disease in a large
      consanguineous family is direct evidence of recessive transmission.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:25895478
    reference_title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      The siblings were compound heterozygotes, and the inheritance mode of autosomal recessive was postulated.
    explanation: >-
      The molecular report documents a compound-heterozygous family.
    quote_role: PRIMARY_RESULT
  - reference: PMID:11807445
    reference_title: 'Three members of a family with pili torti and sensorineural hearing loss: the Bjornstad syndrome.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      We describe a family in which 3 members have the combination of pili torti and varying degrees of hearing
      loss inherited in an apparently autosomal dominant fashion.
    explanation: >-
      This pre-gene-discovery pedigree is a historical phenotypic observation, not evidence of a dominant BCS1L
      allele.
    quote_role: PRIMARY_RESULT
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: UNKNOWN
  notes: >-
    Population prevalence is unknown. Published families and case reports do not supply a population denominator;
    clinical ascertainment and molecular confirmation vary.
  evidence:
  - reference: PMID:24172246
    reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Only few large families have been reported worldwide.
    explanation: >-
      Describes sparse published pedigrees without quantifying population prevalence.
    quote_role: BACKGROUND
    directness: DIRECT
pathophysiology:
- name: BCS1L Rieske Protein Insertion Failure
  biological_scale: MOLECULAR
  description: >-
    BCS1L is an inner-mitochondrial-membrane AAA ATPase that delivers the folded Rieske iron-sulfur protein,
    UQCRFS1, during complex III maturation. Disease-associated genotypes impair this assembly function to varying
    degrees. A Bjornstad-associated p.Arg183His protein retained partial UQCRFS1 binding in a HeLa-cell co-immunoprecipitation
    assay. This supports impaired substrate engagement for that allele but does not directly measure insertion
    kinetics. Neither normal ATP turnover nor an identical substrate-binding lesion has been established for
    every Bjornstad genotype.
  genes:
  - preferred_term: BCS1L
    term:
      id: hgnc:1020
      label: BCS1L
  genetic_context:
    gene:
      preferred_term: BCS1L
      term:
        id: hgnc:1020
        label: BCS1L
    variant_origin: GERMLINE
    functional_impact_category: PARTIAL_LOSS_OF_FUNCTION
    description: >-
      Biallelic pathogenic genotypes with variable residual BCS1L function; both homozygous and compound-heterozygous
      states are reported, including a missense/nonsense pair. The molecular effect depends on the complete
      genotype and cannot be assigned from variant class alone.
  molecular_functions:
  - preferred_term: BCS1L-mediated translocation of folded Rieske protein
    term:
      id: GO:0008320
      label: transmembrane protein transporter activity
  biological_processes:
  - preferred_term: insertion of the Rieske iron-sulfur protein into the inner membrane
    modifier: DECREASED
    term:
      id: GO:0045039
      label: protein insertion into mitochondrial inner membrane
  evidence:
  - reference: PMID:40660675
    reference_title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1,
      similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure
      3G).
    explanation: >-
      The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association,
      not ATPase turnover or translocation rate.
    quote_role: PRIMARY_RESULT
  - reference: PMID:38821922
    reference_title: Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: INDIRECT
    snippet: >-
      Our results show that Bcs1L transitions directly between the ATP and ADP conformations, with no indication
      of the existence of additional intermediate forms, supporting a concerted mechanism.
    explanation: >-
      Purified wild-type mouse Bcs1L with a bovine Rieske extrinsic-domain substrate informs normal transport
      architecture. It does not establish the molecular defect of a human Bjornstad allele.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Complex III Assembly Defect
    description: >-
      Impaired Rieske delivery compromises complex III maturation.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:17314340
      reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: >-
        All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
        electron-transport chain, and increased the production of reactive oxygen species.
      explanation: >-
        The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set.
        Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
      quote_role: PRIMARY_RESULT
- name: Complex III Assembly Defect
  description: >-
    BCS1L dysfunction compromises maturation of Rieske-containing complex III and respiratory supercomplex
    organization. The extent of the assembly abnormality depends on the genotype and assay system; complete
    absence of mature complex III is not established across Bjornstad cases.
  biological_scale: MOLECULAR
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
      electron-transport chain, and increased the production of reactive oxygen species.
    explanation: >-
      The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its
      cell-based biochemical findings should not be generalized to every subsequently reported allele.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Reduced respiratory electron transfer
    description: >-
      Reduced assembly of catalytically competent complex III impairs electron transport.
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:17314340
      reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: DIRECT
      snippet: >-
        All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
        electron-transport chain, and increased the production of reactive oxygen species.
      explanation: >-
        The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set.
        Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
      quote_role: PRIMARY_RESULT
  biological_processes:
  - preferred_term: mitochondrial respiratory chain complex III assembly
    term:
      id: GO:0034551
      label: mitochondrial respiratory chain complex III assembly
    modifier: DECREASED
- name: Reduced respiratory electron transfer
  description: >-
    Reduced mitochondrial electron-transfer activity was measured in the original functional study of BCS1L
    mutants. This is a biochemical consequence distinct from the assembly defect and is not a claim that every
    patient has abnormal muscle respiratory-enzyme testing.
  biological_scale: MOLECULAR
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
      electron-transport chain, and increased the production of reactive oxygen species.
    explanation: >-
      The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its
      cell-based biochemical findings should not be generalized to every subsequently reported allele.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Excess Reactive Oxygen Species Production
    description: >-
      Respiratory dysfunction is associated with increased cellular ROS in the functional study; the intervening
      source-specific redox mechanisms are not fully resolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:17314340
      reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
      supports: SUPPORT
      evidence_source: IN_VITRO
      directness: INDIRECT
      snippet: >-
        All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
        electron-transport chain, and increased the production of reactive oxygen species.
      explanation: >-
        The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set.
        Its cell-based biochemical findings should not be generalized to every subsequently reported allele.
      quote_role: PRIMARY_RESULT
  biological_processes:
  - preferred_term: respiratory electron transport chain
    term:
      id: GO:0022904
      label: respiratory electron transport chain
    modifier: DECREASED
- name: Excess Reactive Oxygen Species Production
  biological_scale: CELLULAR
  description: >-
    The original functional study found increased cellular reactive oxygen species for its tested BCS1L mutants.
    Only the severe complex-III-deficiency mutant group also showed increased mitochondrial content in that
    comparison. These results support disturbed cellular redox metabolism but do not identify incompletely
    assembled complex III as the source of increased superoxide or establish a universal quantitative severity
    rule. Selective tissue injury is a further hypothesis.
  biological_processes:
  - preferred_term: reactive oxygen species metabolic process
    modifier: INCREASED
    term:
      id: GO:0072593
      label: reactive oxygen species metabolic process
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial
      electron-transport chain, and increased the production of reactive oxygen species.
    explanation: >-
      The functional study reports assembly, respiratory and ROS abnormalities for the tested mutant set. Its
      cell-based biochemical findings should not be generalized to every subsequently reported allele.
    quote_role: PRIMARY_RESULT
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      However, only mutations associated with complex III deficiency increased
      mitochondrial content, which further increased the production of reactive
      oxygen species.
    explanation: >-
      The measured mitochondrial-content difference applies to the groups tested in this study; it does not
      by itself explain all tissue selectivity or all later genotypes.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  downstream:
  - target: Cochlear Oxidative Injury
    description: >-
      Increased cellular ROS is proposed to produce preferential cochlear injury.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:17314340
      reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      directness: INDIRECT
      snippet: >-
        Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
        to mitochondrial function, particularly to the production of reactive oxygen species.
      explanation: >-
        This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
        tissue-specific oxidative-injury experiment.
      quote_role: PRIMARY_RESULT
    hypothesis_groups:
    - ROS_TISSUE_VULNERABILITY
  - target: Hair Shaft Keratin Assembly Failure
    description: >-
      ROS is proposed to contribute to abnormal follicular keratin organization, but this was not measured
      in the ultrastructural study.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:17314340
      reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      directness: INDIRECT
      snippet: >-
        Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
        to mitochondrial function, particularly to the production of reactive oxygen species.
      explanation: >-
        This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
        tissue-specific oxidative-injury experiment.
      quote_role: PRIMARY_RESULT
    hypothesis_groups:
    - ROS_TISSUE_VULNERABILITY
- name: Cochlear Oxidative Injury
  biological_scale: TISSUE
  conforms_to: sensorineural_hair_cell_loss#Cochlear Ionic Homeostasis Disruption and Oxidative Stress
  description: >-
    Oxidative injury is a proposed connection between disturbed mitochondrial function and the cochlear hearing
    phenotype. The reviewed studies do not directly demonstrate elevated ROS or hair-cell death in Bjornstad
    cochlear tissue. The annotated hair-cell types are candidate affected cells, not a reported histological
    finding. Relative vulnerability, energy supply and structural cochlear abnormalities require separate evaluation;
    a specific defect in potassium recycling is not established.
  cell_types:
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  - preferred_term: cochlear outer hair cell
    term:
      id: CL:0000601
      label: cochlear outer hair cell
  biological_processes:
  - preferred_term: response to oxidative stress
    term:
      id: GO:0006979
      label: response to oxidative stress
    modifier: ABNORMAL
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    directness: INDIRECT
    snippet: >-
      Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
      to mitochondrial function, particularly to the production of reactive oxygen species.
    explanation: >-
      This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
      tissue-specific oxidative-injury experiment.
    quote_role: PRIMARY_RESULT
  downstream:
  - target: Sensorineural hearing impairment
    description: >-
      Oxidative injury is hypothesized to impair cochlear function; the specific cellular route to hearing
      loss remains unproven.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:17314340
      reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      directness: INDIRECT
      snippet: >-
        Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
        to mitochondrial function, particularly to the production of reactive oxygen species.
      explanation: >-
        This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
        tissue-specific oxidative-injury experiment.
      quote_role: PRIMARY_RESULT
    hypothesis_groups:
    - ROS_TISSUE_VULNERABILITY
- name: Hair Shaft Keratin Assembly Failure
  biological_scale: TISSUE
  description: >-
    Transmission electron microscopy in one Bjornstad patient showed wavy cuticle layers of variable thickness
    and loosely packed cortical keratin intermediate filaments. The authors localized the abnormalities below
    the infundibulum and proposed abnormal disulfide bonding; they did not directly measure a disulfide-bond
    defect or establish ROS as its cause. Ex vivo hair testing found reduced mechanical strength, consistent
    with the fragile, twisted shaft phenotype.
  cell_types:
  - preferred_term: hair follicular keratinocyte
    term:
      id: CL:2000092
      label: hair follicular keratinocyte
  evidence:
  - reference: PMID:27882597
    reference_title: Morphological analyses in fragility of pili torti with Björnstad syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Additionally, the cortex in the samples showed loose keratin intermediate
      filaments (IF).
    explanation: >-
      Reports the ultrastructural cortical abnormality underlying the fragile
      shaft in a Bjornstad patient's hair.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:27882597
    reference_title: Morphological analyses in fragility of pili torti with Björnstad syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Our results suggested that these abnormalities in pili torti had already
      occurred below the infundibulum.
    explanation: >-
      Places the lesion inside the follicle during keratinization rather than in
      the emerged shaft, which is what makes it a follicular rather than a
      cosmetic problem.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  downstream:
  - target: Pili torti
    description: >-
      Abnormal shaft organization and fragility contribute to this hair phenotype; the intervening relationship
      is inferred from morphology and clinical observation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:24172246
      reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        The hair fibers of all the patients were twisted around their axis and
        devoid of any pigment.
      explanation: >-
        Five affected members of one family, all with twisted hair fibers,
        documenting the phenotype within a single kindred.
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
  - target: Brittle hair
    description: >-
      Abnormal shaft organization and fragility contribute to this hair phenotype; the intervening relationship
      is inferred from morphology and clinical observation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:32395403
      reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        with very sparse and brittle hair since birth
      explanation: >-
        Records sparse, brittle hair present from birth in a genetically confirmed
        patient.
      quote_role: PRIMARY_RESULT
      directness: INDIRECT
  - target: Sparse scalp hair
    description: >-
      Abnormal shaft organization and fragility contribute to this hair phenotype; the intervening relationship
      is inferred from morphology and clinical observation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:32395403
      reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        with very sparse and brittle hair since birth
      explanation: >-
        This directly documents reduced scalp hair density in the reported patient.
      quote_role: PRIMARY_RESULT
phenotypes:
- name: Pili torti
  category: Integumentary
  description: >-
    Flattened hair shafts twist around their long axis. Scalp hair is usually most affected, but other hair
    findings vary between reports. Pili torti is a defining sign in combination with hearing loss and is not
    specific to this syndrome alone.
  phenotype_term:
    preferred_term: Pili torti
    term:
      id: HP:0003777
      label: Pili torti
  evidence:
  - reference: PMID:28322498
    reference_title: Novel compound heterozygous mutations in BCS1L gene causing Bjornstad syndrome in two siblings.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bjornstad syndrome is a rare condition characterized by pili torti and
      sensorineural hearing loss associated with pathological variations in
      BCS1L.
    explanation: >-
      The introduction identifies pili torti as a conventional defining feature; it does not estimate its population
      frequency.
    quote_role: BACKGROUND
    directness: DIRECT
  - reference: PMID:24172246
    reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The hair fibers of all the patients were twisted around their axis and
      devoid of any pigment.
    explanation: >-
      Five affected members of one family, all with twisted hair fibers,
      documenting the phenotype within a single kindred.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  notes: >-
    A defining component of the conventional clinical diagnosis; available selected reports do not establish
    population penetrance or a quantitative frequency band.
- name: Sensorineural hearing impairment
  category: Auditory
  description: >-
    Sensorineural hearing loss ranges from moderate to profound and is commonly recognized in infancy or childhood.
    Progression is documented in individual patients, but a uniform progressive course is not established.
    Early hearing assessment and communication support address its developmental impact.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
    onset:
      onset_category: CHILDHOOD
      notes: Hearing loss was noted from 18 months in the 2020 case, within the HPO childhood interval; onset varies between patients.
  evidence:
  - reference: PMID:24172246
    reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In addition the patients had a moderate-to-severe degree of hearing
      impairment.
    explanation: >-
      Documents the severity range of the hearing loss in all five affected
      members of one family.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:30582773
    reference_title: Clinical spectrum of BCS1L Mitopathies and their underlying structural relationships.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Disease phenotypes are varied and can be as mild as Björnstad syndrome,
      characterized by pili torti and sensorineural hearing loss, or as severe as
      GRACILE syndrome, characterized by growth restriction, aminoaciduria,
      cholestasis, iron overload, lactic acidosis, and early death.
    explanation: >-
      A review of all published BCS1L patients confirms sensorineural hearing
      loss as one of the two defining Bjornstad features.
    quote_role: REVIEW_SYNTHESIS
    directness: DIRECT
  - reference: PMID:32395403
    reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      with progressive sensori‐neural hearing loss noted from age 18 months onwards.
    explanation: >-
      The individual case supports possible progression and early onset, not a universal course.
    quote_role: PRIMARY_RESULT
  notes: >-
    A defining component of the conventional clinical diagnosis; available selected reports do not establish
    population penetrance or a quantitative frequency band.
- name: Brittle hair
  category: Integumentary
  description: >-
    Hair shafts can be thin, brittle and easily broken, contributing to sparse or short scalp hair. Fragility
    was present from birth in the ketogenic-diet case report.
  phenotype_term:
    preferred_term: Brittle hair
    term:
      id: HP:0002299
      label: Brittle hair
  evidence:
  - reference: PMID:32395403
    reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      with very sparse and brittle hair since birth
    explanation: >-
      Records sparse, brittle hair present from birth in a genetically confirmed
      patient.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  notes: >-
    Hair fragility is documented clinically and by ex vivo mechanical testing; no population frequency is assigned.
- name: Incomplete partition of the cochlea type I
  category: Auditory
  description: >-
    Bilateral incomplete partition type I was reported in two siblings with profound hearing loss undergoing
    cochlear implantation. This structural malformation requires consideration in surgical assessment; the
    report does not establish its population frequency or a link to oxidative injury.
  phenotype_term:
    preferred_term: Incomplete partition of the cochlea type I
    term:
      id: HP:0011374
      label: Incomplete partition of the cochlea type I
    laterality: BILATERAL
  evidence:
  - reference: PMID:37816838
    reference_title: "Cochlear implantation in Bjornstad syndrome: a case series with literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Cochlear implant surgeries of two siblings (four ears) with profound SNHL
      and bilateral inner ear anomaly (incomplete partition type 1) were
      performed without complications.
    explanation: >-
      Documents the malformation in both affected siblings, bilaterally, on
      preoperative assessment.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  notes: >-
    The evidence is one ascertained family. Its association with BCS1L disease and developmental mechanism
    remain uncertain, so no specific causal path is assigned.
- name: Sparse scalp hair
  description: >-
    Sparse scalp hair may reflect shaft fragility and hair loss. It was present from birth in one molecularly
    diagnosed patient.
  phenotype_term:
    preferred_term: Sparse scalp hair
    term:
      id: HP:0002209
      label: Sparse scalp hair
  evidence:
  - reference: PMID:32395403
    reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      with very sparse and brittle hair since birth
    explanation: >-
      This directly documents reduced scalp hair density in the reported patient.
    quote_role: PRIMARY_RESULT
  category: Integumentary
- name: Intellectual disability
  description: >-
    Intellectual disability was recorded on developmental assessment in a six-year-old with molecularly diagnosed
    Bjornstad syndrome. It is not a defining feature; frequency, contribution of hearing impairment and the
    specific mechanism remain unresolved.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Developmental assessment showed intellectual disability.
    explanation: >-
      The case report directly records this additional manifestation; it does not justify attributing every
      developmental difficulty solely to hearing loss.
    quote_role: PRIMARY_RESULT
  category: Neurodevelopmental
genetic:
- name: BCS1L
  gene_term:
    preferred_term: BCS1L
    term:
      id: hgnc:1020
      label: BCS1L
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    Reported genotypes include homozygous missense variants, compound missense variants, and a missense/nonsense
    pair. The 2007 structural model distinguished the variants then studied, but it does not establish one
    residue class, unaffected ATP turnover, or a deterministic severity rule for every Bjornstad genotype.
    Variant names below follow their source transcripts; segregation and functional findings are distinguished
    from computational predictions.
  variants:
  - name: NM_001079866.1:c.901T>A (p.Tyr301Asn)
    type: MISSENSE
    description: >-
      Homozygous AAA-domain missense allele segregating with Bjornstad syndrome
      in a large consanguineous Pakistani family with five affected individuals.
    evidence:
    - reference: PMID:24172246
      reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A novel homozygous missense mutation c.901T>A was identified, which
        segregated with the disease in the family.
      explanation: >-
        Homozygosity for a missense allele segregating with disease in a large
        consanguineous family is direct evidence of recessive transmission.
      quote_role: PRIMARY_RESULT
      directness: DIRECT
  - name: p.Arg306Cys / p.Arg186Ter, as reported
    description: >-
      Compound missense/nonsense genotype reported in two siblings diagnosed with Bjornstad syndrome; this
      disproves restriction to pairs of missense variants.
    evidence:
    - reference: PMID:25895478
      reference_title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        By analysis of exome of the proband, we identified a novel missense (p.R306C) mutation and a nonsense
        (p.R186*) mutation in the BCS1L gene.
      explanation: >-
        Both variant classes were identified and subsequently confirmed by Sanger sequencing in the report.
      quote_role: PRIMARY_RESULT
  - name: c.232A>G (p.Ser78Gly) / c.794G>A (p.Arg265Gln), NM_001079866.2
    description: >-
      Compound genotype in the diet case report. The Ser78Gly allele is also associated with severe disease
      in other genotypic contexts; its presence alone does not determine the phenotype.
    evidence:
    - reference: PMID:32395403
      reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        We report on a 7‐year‐old female (BCS1L, NM_001079866.2, c.232A>G; p.Ser78Gly, c.794G>A; p.Arg265Gln)
      explanation: >-
        The source supplies the transcript and both alleles of the reported genotype.
      quote_role: PRIMARY_RESULT
  - name: c.649G>C (p.Asp217His) / c.671G>A (p.Arg224His), as reported
    description: >-
      Two missense variants segregated from opposite unaffected parents in the 2021 case. Their specific biochemical
      effects were hypothesized rather than measured.
    evidence:
    - reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
      reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: DIRECT
      snippet: >-
        Further investigation revealed that the patient's unaffected mother carried the heterozygous variant
        in exon 4 (c.649G >C; p. Asp217His), while his unaffected father had the heterozygous variant in exon
        5 (c.671G >A; p. Arg224His).
      explanation: >-
        The full report documents parental segregation, with maternal Asp217His and paternal Arg224His; neither
        parent had the hair/hearing phenotype.
      quote_role: PRIMARY_RESULT
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Refined genetic mapping and DNA sequencing of 44 genes between D2S2210 and
      D2S2244 revealed BCS1L mutations.
    explanation: >-
      The gene-identification study that established BCS1L as the Bjornstad
      syndrome locus.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:24172246
    reference_title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      This mutation results in the amino acid change p.Tyr301Asn and was
      predicted to be pathogenic by bioinformatics tools.
    explanation: >-
      The amino-acid change is reported, but the quoted pathogenicity assessment is computational prediction,
      not a biochemical assay.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
diagnosis:
- name: Hair-shaft microscopy
  description: >-
    Microscopic assessment identifies flattened and twisted hair shafts; electron microscopy documented these
    changes in the cited case. Hair findings need interpretation with audiology and molecular testing because
    pili torti occurs in multiple inherited and acquired conditions.
  evidence:
  - reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Electron microscopy of hairs revealed flattening and twisting around the long axis.
    explanation: >-
      Directly documents diagnostic hair microscopy.
    quote_role: PRIMARY_RESULT
- name: BCS1L sequencing
  description: >-
    BCS1L sequencing with parental segregation can confirm a compatible recessive genotype; exome or broader
    hearing-loss testing can help in atypical presentations. Normal muscle respiratory-chain enzyme activities
    do not exclude BCS1L disease: this limitation was observed in intermediate and severe cases, rather than
    demonstrated to be specific to classic Bjornstad syndrome.
  evidence:
  - reference: PMID:31435670
    reference_title: Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      biochemical analysis of Complex III revealed normal respiratory chain
      enzyme activities in the muscle of both patients
    explanation: >-
      The two tested patients had intermediate multisystem disease and GRACILE syndrome. Their normal muscle
      enzyme assays establish a broader diagnostic limitation, not a finding unique to mild Bjornstad disease.
    directness: INDIRECT
    quote_role: PRIMARY_RESULT
  - reference: PMID:25895478
    reference_title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Our study extends the phenotypic spectrum of Björnstad syndrome and highlights the clinical applicability
      of exome sequencing as a diagnostic tool for atypical Mendelian disorders.
    explanation: >-
      The report supports molecular investigation of atypical hearing and hair presentations.
    quote_role: PRIMARY_RESULT
- name: Audiologic assessment and inner-ear imaging
  description: >-
    Audiologic testing defines hearing severity and response to hearing aids. Imaging is important during cochlear-implant
    assessment because bilateral incomplete partition type I occurred in the reported implanted siblings.
  evidence:
  - reference: PMID:37816838
    reference_title: "Cochlear implantation in Bjornstad syndrome: a case series with literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Cochlear implant surgeries of two siblings (four ears) with profound SNHL
      and bilateral inner ear anomaly (incomplete partition type 1) were
      performed without complications.
    explanation: >-
      Documents the malformation in both affected siblings, bilaterally, on
      preoperative assessment.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
differential_diagnoses:
- name: GRACILE syndrome
  description: >-
    A severe allelic BCS1L disorder with fetal growth restriction, aminoaciduria, cholestasis, iron overload,
    lactic acidosis and early death. Clinical severity and organ involvement depend on the complete genotype;
    a single residue-class rule does not reliably distinguish the syndromes.
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      BCS1L mutations cause disease phenotypes ranging from highly restricted
      pili torti and sensorineural hearing loss (the Björnstad syndrome) to
      profound multisystem organ failure (complex III deficiency and the GRACILE
      syndrome).
    explanation: >-
      States the allelic relationship and the clinical distance between the two
      ends of the BCS1L spectrum.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: BCS1L-related complex III deficiency
  description: >-
    Broader BCS1L disease can involve renal tubulopathy, hepatic dysfunction, encephalopathy, seizures or neuropathy.
    Biochemical complex III impairment is variably detected across tissues. These multisystem presentations
    should not automatically be assigned to the predominantly hair-and-hearing phenotype.
  evidence:
  - reference: PMID:22991165
    reference_title: Clinical and biochemical features associated with BCS1L mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All affected members of the families have an identical mutation in this
      gene, mutations of which are recognized causes of Björnstad syndrome,
      GRACILE syndrome and a syndrome of neonatal tubulopathy, encephalopathy,
      and liver failure (MIM 606104) leading to isolated mitochondrial
      respiratory chain complex III deficiency.
    explanation: >-
      Enumerates the allelic BCS1L disorders that must be distinguished from the
      restricted Bjornstad phenotype.
    quote_role: BACKGROUND
    directness: DIRECT
- name: BCS1L Mitopathies (intermediate phenotypes)
  description: >-
    A proposed name for intermediate BCS1L phenotypes with variable renal, hepatic, neurologic and growth manifestations.
    Published labels overlap; assessment should characterize the organ findings and complete genotype rather
    than rely on the syndrome name alone.
  evidence:
  - reference: PMID:30582773
    reference_title: Clinical spectrum of BCS1L Mitopathies and their underlying structural relationships.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We propose a change in nomenclature that unifies the intermediate
      phenotype under "BCS1L Mitopathies".
    explanation: >-
      Records the proposed intermediate category so that entries between the two
      poles are not forced into the Bjornstad label.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
- name: Menkes disease
  description: >-
    An X-linked copper transport disorder (ATP7A) that also produces pili torti,
    but with progressive neurodegeneration, seizures, hypotonia and connective
    tissue laxity from infancy, and with low serum copper and ceruloplasmin.
    Considered because pili torti on hair microscopy is the shared finding.
  evidence:
  - reference: PMID:34501349
    reference_title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      In patients with Menkes disease, neurodegenerative signs, including seizures, feeding difficulties, hypotonia,
      and psychomotor retardation usually occur at 2–3 months of age [5].
    explanation: >-
      The review contrasts early neurologic disease with the predominantly hair-and-hearing presentation.
    quote_role: REVIEW_SYNTHESIS
- name: Bazex-Dupre-Christol syndrome
  description: >-
    An X-linked disorder characterized by follicular atrophoderma, hypotrichosis, milia and early basal cell
    carcinomas. Pili torti may overlap, while the cutaneous tumour predisposition and follicular atrophoderma
    distinguish its usual presentation.
  evidence:
  - reference: PMID:34501349
    reference_title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Bazex-Dupré-Christol syndrome is an X-linked semidominant disorder characterized by follicular atrophoderma,
      multiple milia, hypotrichosis, hypohidrosis, and an early development of basal cell carcinomas [54,55].
    explanation: >-
      The review supplies the distinguishing cutaneous phenotype. Its gene attribution is not adopted here.
    quote_role: REVIEW_SYNTHESIS
- name: Crandall syndrome
  description: >-
    Pili torti and sensorineural hearing loss can overlap, while hypogonadism distinguishes the reported Crandall
    phenotype.
  evidence:
  - reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      While pili torti and sensorineural hearing loss have been described in both Bjornstad syndrome and Crandall's
      syndrome, the latter is differentiated by hypogonadism.
    explanation: >-
      The discussion identifies the shared features and clinical distinction.
    quote_role: BACKGROUND
treatments:
- name: Cochlear implantation for profound hearing loss
  description: >-
    Bilateral cochlear implantation was reported in two siblings with profound sensorineural hearing loss unresponsive
    to conventional hearing aids. Surgery was completed without observed complications and postoperative audiometry
    improved. The small family report supports considering implantation under usual candidacy assessment, not
    a syndrome-wide safety or efficacy estimate.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: cochlear implant placement
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  evidence:
  - reference: PMID:37816838
    reference_title: "Cochlear implantation in Bjornstad syndrome: a case series with literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A retrospective report of two siblings with Bjornstad syndrome suffering
      profound SNHL unresponsive to conventional hearing aids treated with
      bilateral simultaneous cochlear implantation.
    explanation: >-
      Documents the small retrospective family report and its indication.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:37816838
    reference_title: 'Cochlear implantation in Bjornstad syndrome: a case series with literature review.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      Postoperative audiometric measurements showed a significiant improvement in pure-tone threshold and a
      word recognition score.
    explanation: >-
      The two-sibling report documents improvement; it does not establish a population-level efficacy estimate.
    quote_role: PRIMARY_RESULT
  notes: >-
    The evidence comprises two siblings with four implanted ears and bilateral incomplete partition type I.
    Anatomical and audiologic evaluation remain necessary; treatment outcomes cannot be generalized from this
    family.
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
- name: Modified Atkins (mild ketogenic) diet
  description: >-
    A modified Atkins diet was used for four months in one seven-year-old with a reported Bjornstad genotype.
    Hair growth improved and was lost again after the diet stopped; hearing did not improve. There was no control
    group or measured correction of oxidative stress. Aminoaciduria was neither confirmed nor excluded, leaving
    a potential additional contributor to hair loss.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: mild ketogenic (modified Atkins) diet
    term:
      id: NCIT:C15447
      label: Dietary Intervention
  target_mechanisms:
  - target: Excess Reactive Oxygen Species Production
    description: >-
      Reduced oxidative stress is a proposed rationale from general ketogenic-diet literature; the patient
      report did not measure this mechanism.
    evidence:
    - reference: PMID:32395403
      reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
      supports: SUPPORT
      directness: INDIRECT
      evidence_source: OTHER
      snippet: >-
        Ketogenic diets stimulate mitochondrial biogenesis, improve mitochondrial
        function and decrease oxidative stress
      explanation: >-
        States the proposed mechanism of action against the oxidative-stress
        node; the inference from general ketogenic-diet biology to this disorder
        is not itself tested, hence INDIRECT.
      quote_role: BACKGROUND
  evidence:
  - reference: PMID:32395403
    reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There was improved hair growth during MAD in this individual with BCS1l
      related mitochondrial disease
    explanation: >-
      The primary observation, stated by the authors with the hedging their
      single-patient design requires.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:32395403
    reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Figure 1F shows that the hair was lost again 6 months after cessation of
      MAD.
    explanation: >-
      Withdrawal and relapse in the same patient is the strongest element of this
      report, though it remains a single uncontrolled observation.
    quote_role: PRIMARY_RESULT
    directness: DIRECT
  - reference: PMID:32395403
    reference_title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      A 3‐day dietary history indicated an adequate diet with no protein deficiency but aminoaciduria, as a
      possible contributing cause for alopecia, was not confirmed or excluded.
    explanation: >-
      The report identifies a possible confounder of the hair response.
    quote_role: PRIMARY_RESULT
  notes: >-
    This single observation does not establish a disease-modifying therapy or the safety and efficacy of a
    ketogenic diet across patients. The family stopped because of carbohydrate cravings and lack of hearing
    improvement.
- name: Genetic counseling
  description: >-
    For two confirmed heterozygous carrier parents, each pregnancy has a Mendelian 25% probability of a child
    with the biallelic genotype. Counseling should use the familial variants and clinical spectrum, and explain
    that outcomes cannot be predicted from one allele alone.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The Björnstad syndrome, an autosomal recessive disorder associated with
      sensorineural hearing loss and pili torti, is caused by mutation of a
      previously unidentified gene on chromosome 2q34-36.
    explanation: >-
      The recessive inheritance that determines the recurrence risk discussed in
      counseling.
    quote_role: BACKGROUND
    directness: DIRECT
- name: Hearing aids and audiologic follow-up
  description: >-
    Hearing aids and ongoing audiologic assessment are used for the hearing phenotype. Benefit and need for
    implantation depend on individual hearing severity and response.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: hearing-aid rehabilitation
    term:
      id: NCIT:C15315
      label: Rehabilitation
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    reference_title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: DIRECT
    snippet: >-
      had begun wearing hearing aids at the age of 4 years.
    explanation: >-
      The case documents audiologic follow-up and hearing-aid use, without quantifying benefit.
    quote_role: PRIMARY_RESULT
- name: Gentle hair care
  description: >-
    Avoiding excessive grooming, heat, chemical treatment and mechanical trauma can reduce damage to fragile
    hair. This is general pili-torti care, not evidence that BCS1L function is restored.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: gentle hair care and avoidance of shaft trauma
  target_phenotypes:
  - preferred_term: Brittle hair
    term:
      id: HP:0002299
      label: Brittle hair
  evidence:
  - reference: PMID:34501349
    reference_title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      There is no specific treatment of pili torti. The avoidance of trauma to the hair is recommended.
    explanation: >-
      The review supports general supportive care for hair fragility.
    quote_role: REVIEW_SYNTHESIS
discussions:
- discussion_id: bjornstad_tissue_restriction
  kind: KNOWLEDGE_GAP
  prompt: >-
    Why do many BCS1L genotypes preferentially affect hearing and hair, while other genotypes cause broader
    organ disease?
  attaches_to:
  - pathophysiology#Excess Reactive Oxygen Species Production
  - pathophysiology#Cochlear Oxidative Injury
  rationale: >-
    Increased cellular ROS and a mitochondrial-content difference were observed in the original mutant comparison,
    but neither establishes why particular tissues are affected. The reviewed sources do not provide allele-matched
    cochlear and follicular measurements. Additional clinical manifestations can occur, so tissue restriction
    is relative. Comparable oxidative burden can have different consequences because tissues differ in repair,
    antioxidant capacity and energy demand.
  proposed_experiments:
  - experiment_id: bjornstad_allele_matched_tissue_ros
    name: Allele-matched tissue comparison of oxidative burden
    description: >-
      Compare matched biallelic Bjornstad and severe BCS1L genotypes in isogenic human iPSC-derived inner-ear,
      hair-follicle and hepatic models. Measure complex III assembly, respiration, ROS, cell survival and follicular
      organization, and add genetic correction plus independently verified ROS-lowering interventions.
    would_support:
    - pathophysiology#Cochlear Oxidative Injury
    supporting_outcome:
    - Cochlear and follicular dysfunction tracks with oxidative injury and improves when ROS is normalized, with effects distinguished from restoration of respiration.
    would_refute:
    - pathophysiology#Cochlear Oxidative Injury
    refuting_outcome:
    - Cochlear and follicular injury persists despite sustained normalization of ROS with multiple validated interventions, while BCS1L correction rescues the phenotype; this would argue against ROS as the principal mediator.
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    directness: INDIRECT
    snippet: >-
      Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
      to mitochondrial function, particularly to the production of reactive oxygen species.
    explanation: >-
      This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
      tissue-specific oxidative-injury experiment.
    quote_role: PRIMARY_RESULT
- discussion_id: bjornstad_no_faithful_model
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Which experimental systems can reproduce the hair and hearing phenotype for clinically matched BCS1L genotypes?
  attaches_to:
  - pathophysiology#Complex III Assembly Defect
  rationale: >-
    The reviewed patient-cell, yeast, HeLa and purified-protein systems resolve assembly or substrate interactions
    but do not reproduce a cochlea and hair follicle together. Severe BCS1L animal models cannot automatically
    validate a predominantly hair-and-hearing mechanism. A disease-matched tissue model remains a gap in this
    evidence set; this is not an exhaustive claim that no relevant model exists.
  evidence:
  - reference: PMID:40660675
    reference_title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1,
      similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure
      3G).
    explanation: >-
      The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association,
      not ATPase turnover or translocation rate.
    quote_role: PRIMARY_RESULT
  - reference: PMID:38821922
    reference_title: Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: INDIRECT
    snippet: >-
      Our results show that Bcs1L transitions directly between the ATP and ADP conformations, with no indication
      of the existence of additional intermediate forms, supporting a concerted mechanism.
    explanation: >-
      Purified wild-type mouse Bcs1L with a bovine Rieske extrinsic-domain substrate informs normal transport
      architecture. It does not establish the molecular defect of a human Bjornstad allele.
    quote_role: PRIMARY_RESULT
- discussion_id: bjornstad_variant_mechanisms
  kind: KNOWLEDGE_GAP
  prompt: Which biochemical steps distinguish individual Bjornstad genotypes from other BCS1L presentations?
  attaches_to:
  - pathophysiology#BCS1L Rieske Protein Insertion Failure
  rationale: >-
    The 2007 residue-interface versus ATP-site classification was a homology-based explanation of the alleles
    studied then. New wild-type structural work and residual Rieske binding by p.Arg183His refine the model
    but do not prove normal ATP turnover for every Bjornstad variant. Reported compound genotypes can pair
    alleles associated with different clinical spectra, including a missense/nonsense combination. Assays of
    the complete genotype and multiple steps in transport are needed.
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    directness: DIRECT
    snippet: >-
      Patients with the Björnstad syndrome have mutations that alter residues involved in protein-protein interactions,
      whereas mutations in patients with complex III deficiency alter ATP-binding residues, as deduced from
      the crystal structure of a related AAA-family ATPase.
    explanation: >-
      The residue-role assignments are computational deductions for the original mutant set, not a universal
      clinical classification.
    quote_role: PRIMARY_RESULT
  - reference: PMID:40660675
    reference_title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: DIRECT
    snippet: >-
      Co‐immunoprecipitation assays showed that p.L280F exhibited markedly reduced interaction with UQCRFS1,
      similar to the severe GRACILE‐associated S78G variant, whereas p.R183H retained partial binding (Figure
      3G).
    explanation: >-
      The HeLa-cell assay includes a Bjornstad-associated comparator, p.Arg183His. It measures protein association,
      not ATPase turnover or translocation rate.
    quote_role: PRIMARY_RESULT
  - reference: PMID:39053894
    reference_title: 'Pathological variants in nuclear genes causing mitochondrial complex III deficiency: An update.'
    supports: SUPPORT
    evidence_source: OTHER
    directness: INDIRECT
    snippet: >-
      However, despite these developments, the molecular pathological mechanisms underlying the clinical heterogeneity
      in different cases of mitochondrial cIII deficiency are still not fully comprehended.
    explanation: >-
      The review describes unresolved clinical heterogeneity across complex III disorders, providing broader
      context rather than allele-specific experimental proof.
    quote_role: REVIEW_SYNTHESIS
mechanistic_hypotheses:
- hypothesis_group_id: ROS_TISSUE_VULNERABILITY
  hypothesis_label: Preferential oxidative injury in cochlear and follicular tissues
  status: EMERGING
  description: >-
    Cellular ROS abnormalities and the predominantly hair-and-hearing phenotype support a proposed oxidative-vulnerability
    model. Direct measurement and rescue in the affected tissues are needed to establish these causal links;
    occasional additional clinical findings and cochlear malformations are not explained by the model.
  evidence:
  - reference: PMID:17314340
    reference_title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    directness: INDIRECT
    snippet: >-
      Mutations that cause the Björnstad syndrome illustrate the exquisite sensitivity of ear and hair tissues
      to mitochondrial function, particularly to the production of reactive oxygen species.
    explanation: >-
      This is the authors' mechanistic interpretation of the clinical and biochemical findings, not a direct
      tissue-specific oxidative-injury experiment.
    quote_role: PRIMARY_RESULT
references:
- reference: PMID:11807445
  title: 'Three members of a family with pili torti and sensorineural hearing loss: the Bjornstad syndrome.'
- reference: PMID:17314340
  title: Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
- reference: PMID:22991165
  title: Clinical and biochemical features associated with BCS1L mutation.
- reference: PMID:24172246
  title: Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
- reference: PMID:25895478
  title: Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
- reference: PMID:27882597
  title: Morphological analyses in fragility of pili torti with Björnstad syndrome.
- reference: PMID:28322498
  title: Novel compound heterozygous mutations in BCS1L gene causing Bjornstad syndrome in two siblings.
- reference: PMID:30582773
  title: Clinical spectrum of BCS1L Mitopathies and their underlying structural relationships.
- reference: PMID:31435670
  title: Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease.
- reference: PMID:32395403
  title: Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
- reference: PMID:34501349
  title: 'Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.'
- reference: PMID:37816838
  title: 'Cochlear implantation in Bjornstad syndrome: a case series with literature review.'
- reference: PMID:38821922
  title: Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.
- reference: PMID:39053894
  title: 'Pathological variants in nuclear genes causing mitochondrial complex III deficiency: An update.'
- reference: PMID:40660675
  title: "BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy."
- reference: PMID:41466500
  title: 'Björnstad Syndrome With Late-Onset Alopecia Mimicking Androgenetic Alopecia: Histopathological and Genetic Findings.'
- reference: PMID:41814923
  title: Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants.
- reference: url:https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
  title: https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
📚

References & Deep Research

References

18
Three members of a family with pili torti and sensorineural hearing loss: the Bjornstad syndrome.
No top-level findings curated for this source.
Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome.
No top-level findings curated for this source.
Clinical and biochemical features associated with BCS1L mutation.
No top-level findings curated for this source.
Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome.
No top-level findings curated for this source.
Exome sequencing reveals novel BCS1L mutations in siblings with hearing loss and hypotrichosis.
No top-level findings curated for this source.
Morphological analyses in fragility of pili torti with Björnstad syndrome.
No top-level findings curated for this source.
Novel compound heterozygous mutations in BCS1L gene causing Bjornstad syndrome in two siblings.
No top-level findings curated for this source.
Clinical spectrum of BCS1L Mitopathies and their underlying structural relationships.
No top-level findings curated for this source.
Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease.
No top-level findings curated for this source.
Ketogenic diet for treating alopecia in BCS1l-related mitochondrial disease (Bjornstad syndrome).
No top-level findings curated for this source.
Pili Torti: A Feature of Numerous Congenital and Acquired Conditions.
No top-level findings curated for this source.
Cochlear implantation in Bjornstad syndrome: a case series with literature review.
No top-level findings curated for this source.
Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate.
No top-level findings curated for this source.
Pathological variants in nuclear genes causing mitochondrial complex III deficiency: An update.
No top-level findings curated for this source.
BCS1L-Associated Disease: 5'-UTR Variant Shifts the Phenotype Towards Axonal Neuropathy.
No top-level findings curated for this source.
Björnstad Syndrome With Late-Onset Alopecia Mimicking Androgenetic Alopecia: Histopathological and Genetic Findings.
No top-level findings curated for this source.
Combination therapy with tofacitinib and minoxidil for Bjornstad syndrome caused by novel BCS1L gene variants.
No top-level findings curated for this source.
https://cmb.ump.edu.vn/upload/userfiles/images/B%C3%80I%20B%C3%81O/2021_Alopecia%20and%20hearing%20loss%20in%20a%20boy.pdf
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Review round 1: term, evidence-grading and literature-sweep fixes · 2026-09-04T06:01:31Z · View source

Addresses the CHANGES_REQUESTED review on PR #10895. (1) Replaced GO:0016887 ATP hydrolysis activity / DECREASED on BCS1L Rieske Protein Insertion Failure with GO:0140662 ATP-dependent protein folding chaperone and no modifier: the cited paper says Bjornstad alleles alter protein-protein interaction residues and that only complex III deficiency alleles disrupt ATP-dependent assembly, so a decreased ATPase rate was the opposite of the evidence. (2) Replaced GO:0016226 iron-sulfur cluster assembly with GO:0045039 protein insertion into mitochondrial inner membrane / DECREASED; GO:0016226 is de novo Fe-S cluster biosynthesis, which BCS1L does not do. (3) Re-graded three PMID:17314340 evidence items away from HUMAN_CLINICAL: two functional-analysis results to IN_VITRO and the homology-model residue assignment to COMPUTATIONAL. (4) Manual PubMed sweep in place of a deep-research artifact (33 hits for Bjornstad syndrome, 106 for BCS1L, all screened by title). It found PMID:37816838, a 2024 cochlear implantation case series that the entry did not cite and whose existence contradicted a notes claim that no Bjornstad-specific implantation series had been published; added two evidence items to the implantation treatment, corrected the notes, and added a new phenotype Incomplete partition of the cochlea type I (HP:0011374) reported bilaterally in both siblings. Confirmed no GeneReviews chapter exists for Bjornstad syndrome; the single BCS1L GeneReviews hit (PMID:26425749) is the nuclear-gene Leigh syndrome spectrum overview. (5) Review suggestions taken: HP:0000750 bound to Speech and language delay; GO:0006979 response to oxidative stress added to the conforming cochlear node so the module conformance is checkable, with the omitted potassium branch and the skipped hair-cell-death node explained in the node description; Brittle hair given notes explaining why no frequency band is assigned. Kept PMID:27882597 graded IN_VITRO: transmission electron microscopy and tensile testing of plucked hair is an ex vivo specimen assay, which CLAUDE.md classifies as IN_VITRO. Validated with just validate, validate-terms, count-verified-snippets (34/34), check-entity-refs, check-duplicate-keys, check-causal-targets, check-enum-values, check-qualifier-terms.

Falcon ▸
Björnstad Syndrome: Disease-Characteristics Research Report
Edison Scientific Literature 27 citations 2026-09-03T23:58:04.484385

Björnstad Syndrome: Disease-Characteristics Research Report

Scope and evidence date. This report distinguishes classic Björnstad syndrome—pili torti with sensorineural hearing loss—from severe multisystem BCS1L-related complex III disease. Evidence for the classic syndrome remains limited to small pedigrees and case reports; consequently, percentages, penetrance estimates, survival curves, and treatment-response rates generally cannot be calculated reliably.

Executive summary

Björnstad syndrome is an extremely rare, autosomal-recessive mitochondrial disorder caused by biallelic germline variants in BCS1L. Its defining manifestations are congenital or early-childhood bilateral sensorineural hearing loss and pili torti, a hair-shaft defect in which flattened shafts twist approximately 180° at irregular intervals. Open Targets identifies BCS1L as the only associated target for Björnstad syndrome, MONDO:0009872. Classic disease is usually limited to hair and hearing and is considered the mild end of the BCS1L phenotypic spectrum; renal, hepatic, neurologic, cardiac, or severe metabolic involvement should prompt classification as broader BCS1L-related mitochondrial disease rather than uncomplicated Björnstad syndrome. (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2, tegelberg2017respiratorychaincomplex pages 1-2)

The major recent advance is mechanistic rather than therapeutic. A May 2024 cryo-EM study showed that the BCS1L heptamer uses a concerted ATPase cycle to translocate folded Rieske iron–sulfur protein during late respiratory-complex-III assembly. A July 2024 review confirms that BCS1L variants are the most frequent nuclear genetic cause of complex III deficiency. No approved disease-modifying therapy or Björnstad-specific interventional trial was identified. (zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7)

The following table provides a compact knowledge-base mapping; the narrative afterward expands the principal fields.

Knowledge-base field Classic Björnstad syndrome Broader BCS1L-related disease / ontology annotation Evidence
Disease identity and identifiers Rare Mendelian mitochondrial disorder defined by pili torti plus bilateral sensorineural hearing loss. Synonyms: Björnstad syndrome, Bjornstad syndrome, pili torti–sensorineural hearing loss syndrome. MONDO:0009872; OMIM phenotype: 262000. Do not equate classic Björnstad syndrome with GRACILE syndrome or all BCS1L-related complex III deficiencies. OMIM 603647 refers to BCS1L, not the classic phenotype. A dedicated ICD-10/ICD-11 or MeSH disease code was not established in the reviewed evidence. (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10)
Inheritance Autosomal recessive; affected individuals generally have biallelic germline BCS1L variants. For two carrier parents, expected Mendelian risks per pregnancy are 25% affected, 50% carrier and 25% unaffected/non-carrier. Variable expressivity occurs across BCS1L genotypes. Anticipation, protective alleles and established germline-mosaicism effects have not been demonstrated. Consanguinity increases the probability of homozygous disease alleles but is not required. (hinson2007missensemutationsin pages 1-2, siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
Causal gene and protein BCS1L is the sole established causal gene; it encodes a 419-aa, inner-mitochondrial-membrane AAA-family ATPase/chaperone. Open Targets identifies BCS1L as the only associated target for MONDO:0009872. Protein architecture includes an N-terminal mitochondrial targeting/transmembrane region, a Bcs1-specific middle domain and a C-terminal AAA ATPase domain. BCS1L acts during late complex III maturation. (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2, zhan2024conformationsofbcs1l pages 2-3, blazquez2013mitochondrialcomplexiii pages 7-10)
Core phenotype: hearing Congenital or first-year-onset, bilateral sensorineural/cochlear hearing impairment; severity ranges from moderate to profound and may progress. One five-patient pedigree had thresholds of 70–110 dB, with moderate-to-severe childhood and severe-to-profound adult loss. Suggested HPO: Sensorineural hearing impairment (HP:0000407), bilateral hearing impairment, congenital hearing impairment, progressive hearing impairment. Conductive loss, absent auditory canals, encephalopathy or seizures suggest a broader phenotype or another diagnosis rather than uncomplicated classic Björnstad syndrome. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2, qurashi2022clinicalanddiagnostic pages 1-2)
Core phenotype: hair Pili torti consists of flattened hair shafts twisted approximately 180° at irregular intervals, producing coarse, lusterless, brittle scalp hair, hypotrichosis or nonscarring alopecia. Hair loss may begin at 2–3 months. Suggested HPO: Pili torti, brittle hair, sparse scalp hair/hypotrichosis, nonscarring alopecia. Eyebrow, eyelash or body-hair involvement is variable; one pedigree had eyelash loss, whereas another case had normal eyebrows and eyelashes. Pili torti is not specific and also occurs in Menkes disease and other inherited or acquired disorders. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
Other reported phenotypes Occasional short stature, anhidrosis, light-colored eyes or intellectual disability have been reported, but frequencies and causal specificity are uncertain. Teeth, nails, palms and soles may be normal. Renal Fanconi/tubular disease, lactic acidosis, liver failure, growth restriction, microcephaly, cardiomyopathy, encephalopathy and early death belong mainly to the broader BCS1L complex III-deficiency spectrum, not the defining classic phenotype. Suggested HPO terms should be attached only when observed in the individual. (siddiqi2013novelmutationin pages 1-2, qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2, cunatova2024pathologicalvariantsin pages 5-7)
Example classic-associated variants Reported biallelic variants include homozygous c.901T>A (p.Tyr301Asn) and compound-heterozygous c.649G>C (p.Asp217His) plus c.671G>A (p.Arg224His). The p.Tyr301Asn allele segregated in five affected relatives and was absent from 137 Pakistani controls and 1000 Genomes. Variant classification must use current ClinVar/ACMG evidence, segregation, population frequency and functional data; a published “novel” or predicted-damaging result alone is not equivalent to a current pathogenic classification. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
Broader-spectrum variant examples Not defining examples of uncomplicated Björnstad syndrome. c.142A>G (p.Met48Val) was associated with deafness, tubulopathy, growth retardation and microcephaly; c.712A>G (p.Ser328Gly) with severe multisystem neonatal disease; and c.548G>A (p.Arg183His) plus c.1061_1062insCTA (p.Gly354delinsGlyTyr) with complex III deficiency and multisystem manifestations. (qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2)
Ordered molecular mechanism Biallelic BCS1L dysfunction leads to defective late-stage complex III assembly; this results in reduced respiratory-chain function and altered redox handling; tissue-selective energetic/oxidative injury is inferred to cause dysfunction of cochlear sensory cells and hair follicles; this leads to hearing loss and pili torti. BCS1L normally translocates folded, Fe–S-cluster-containing UQCRFS1/Rieske ISP from the matrix side across the inner membrane and inserts it into nascent complex III. Failed insertion causes Rieske-deficient precomplex accumulation, impaired complex III/respirasome assembly and altered ROS. Suggested GO: mitochondrial respiratory-chain complex III assembly; protein translocation across mitochondrial inner membrane; ubiquinol-to-cytochrome-c electron transport; oxidative phosphorylation; response to oxidative stress. (hinson2007missensemutationsin pages 1-2, tegelberg2017respiratorychaincomplex pages 1-2, hinson2007missensemutationsin pages 9-10, cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7)
Key 2024 mechanistic development The structural work explains the normal machine affected by Björnstad variants but does not itself establish variant-specific clinical effects. Cryo-EM showed heptameric BCS1L subunits switching concertedly between uniform ATP- and ADP-bound conformations rather than using a sequential threading staircase. Folded ISP can be trapped in the all-ADP state and is proposed to be released in the apo state; ISP stimulated ATPase activity by about 50%. A 2024 review identifies BCS1L variants as the most frequent nuclear cause of complex III deficiency. (zhan2024conformationsofbcs1l pages 1-2, zhan2024conformationsofbcs1l pages 2-3, cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7)
Anatomy, cells and compartments Primary sites: cochlea/inner ear and scalp hair follicle/hair shaft. Suggested UBERON: cochlea, organ of Corti, inner ear, skin of scalp, hair follicle. Suggested CL: auditory hair cell, inner hair cell, outer hair cell, hair-follicle keratinocyte. Subcellular sites: mitochondrial inner membrane (GO:0005743), mitochondrial matrix, respiratory-chain complex III (GO:0005750) and respirasome (GO:0070469). Exact vulnerable cell population in human Björnstad syndrome remains incompletely demonstrated; localization to cochlear and follicular cells is partly inferential. (hinson2007missensemutationsin pages 1-2, trinh2021alopeciaandhearing pages 1-2, zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 1-4)
Diagnosis Suspect from the combination of early bilateral sensorineural hearing loss and brittle/sparse hair. Confirm pili torti by trichoscopy or light/electron microscopy and characterize hearing with age-appropriate audiometry, otoacoustic emissions and auditory brainstem testing. Confirm with two clinically significant BCS1L variants in trans and parental segregation where possible. A hearing-loss/mitochondrial gene panel, WES or WGS is appropriate when single-gene testing is negative or the phenotype is broad. Respiratory-chain enzyme assays, blue-native PAGE and muscle/fibroblast studies can support pathogenicity, but complex III deficiency may be tissue-dependent or missed by routine assays. CMA, karyotype, FISH, mtDNA and repeat-expansion tests are not first-line for the classic phenotype unless other findings indicate them. (trinh2021alopeciaandhearing pages 1-2, tegelberg2017respiratorychaincomplex pages 1-2, jackson2016anovelmutation pages 1-2)
Differential diagnosis Crandall syndrome may combine pili torti and hearing loss but includes hypogonadism. Other considerations include Menkes disease, isolated pili torti, ectodermal dysplasias, Netherton syndrome and acquired pili torti. Multisystem metabolic disease requires evaluation for GRACILE syndrome, broader BCS1L mitopathy and other nuclear complex III disorders. Genetic testing is important because pili torti is a nonspecific hair-shaft marker. (trinh2021alopeciaandhearing pages 1-2)
Treatment and implementation No curative or approved genotype-specific therapy. Early audiology, hearing aids, speech/language support and educational accommodations are standard; cochlear implantation may be considered for severe/profound loss under usual audiological criteria. Gentle hair care and cosmetic support address fragility. Suggested NCIT concepts: Hearing Aid Device, Cochlear Implantation, Speech Therapy, Genetic Counseling. Broader disease warrants mitochondrial-specialist surveillance and organ-directed care. Vitamin/CoQ10 “cocktails” have only anecdotal evidence and cannot be considered proven Björnstad therapy. No Björnstad-specific interventional trial was identified. (trinh2021alopeciaandhearing pages 1-2)
Prognosis and quality of life Classic disease is chronic and lifelong; hearing impairment can substantially affect communication, language, education and employment, while hair abnormalities mainly affect appearance and psychosocial well-being. Classic Björnstad syndrome is generally described as compatible with normal lifespan. Prognosis cannot be extrapolated from classic disease to severe BCS1L mitopathy, in which hepatic, renal, neurologic or cardiac involvement may cause early mortality. No syndrome-specific survival curves, validated quality-of-life scores or prognostic biomarkers were found. (siddiqi2013novelmutationin pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10, cunatova2024pathologicalvariantsin pages 5-7)
Epidemiology and population Described as extremely rare; no reliable population prevalence, incidence, carrier frequency or sex ratio was found. Both sexes are affected. Reports span multiple geographic ancestries and are dominated by individual cases and small pedigrees. Consanguineous families have enabled discovery of homozygous alleles, but no classic Björnstad founder effect is established in the reviewed evidence. Do not calculate prevalence from published case counts because ascertainment and publication bias are substantial. (hinson2007missensemutationsin pages 1-2, siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
Prevention and screening The genotype cannot be prevented by lifestyle or vaccination. Cascade testing, carrier testing of adult relatives, genetic counseling, prenatal diagnosis and PGT-M are possible after familial variants are established. Population newborn screening is not available; early hearing screening can reduce developmental consequences. No environmental protective factor, gene–environment interaction or prophylactic medication has been established. Avoiding excessive mechanical/chemical hair trauma may reduce breakage but does not alter mitochondrial disease. (hinson2007missensemutationsin pages 1-2, trinh2021alopeciaandhearing pages 1-2)
Models and comparative biology No validated animal model was found that specifically reproduces the classic hair-plus-hearing Björnstad phenotype. No naturally occurring veterinary counterpart or zoonotic/transmission relevance was identified. Yeast Saccharomyces cerevisiae Bcs1 models support variant validation and compound screening. Bcs1l mutant/knock-in mice reproduce aspects of broader complex III deficiency, hepatopathy and macrophage abnormalities, but only partially phenocopy human multisystem disease and should not be treated as classic Björnstad models. (tegelberg2017respiratorychaincomplex pages 1-2, zhan2024conformationsofbcs1l pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10)
Key evidence gaps Phenotype frequencies, penetrance, natural-history trajectories, hearing progression rates, quality of life and long-term intervention outcomes remain undefined because evidence consists mainly of case reports and small families. No validated modifier genes, protective variants, epigenetic signature, disease-specific transcriptomic/proteomic/metabolomic profile, single-cell or spatial atlas, prognostic biomarker, classic-syndrome animal model, disease-modifying therapy or dedicated clinical trial was identified. The mechanism of selective cochlear and follicular vulnerability remains partly inferred. (hinson2007missensemutationsin pages 9-10, trinh2021alopeciaandhearing pages 2-2, zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 5-7)

Table: Concise knowledge-base mapping of classic Björnstad syndrome, with explicit separation from severe BCS1L-related complex III disease. It integrates clinical, genetic, mechanistic, ontology, diagnostic and management fields while highlighting 2024 structural advances and evidence gaps.

1. Disease information

Definition and identifiers

  • Preferred name: Björnstad syndrome; ASCII form, Bjornstad syndrome.
  • Synonyms: pili torti–sensorineural hearing loss syndrome; BCS1L-related Björnstad syndrome; BJS.
  • MONDO: MONDO:0009872.
  • OMIM: the classic phenotype is commonly indexed as #262000. Some papers report #603647, but that number refers to the BCS1L gene entry; databases should not silently merge the gene and phenotype records. (OpenTargets Search: Bjornstad syndrome-BCS1L, siddiqi2013novelmutationin pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10)
  • Gene: BCS1L, approved name “BCS1 ubiquinol-cytochrome c reductase complex chaperone”; Ensembl ENSG00000074582. (OpenTargets Search: Bjornstad syndrome-BCS1L)
  • Orphanet/ICD/MeSH: no dedicated Orphanet, ICD-10, ICD-11, or MeSH identifier was established from the retrieved evidence. An implementation should preserve this as “not verified,” rather than assigning a nonspecific deafness or mitochondrial-disease code as an exact equivalent.

The evidence summarized here is aggregated disease-level literature and database evidence, not individual EHR data. Patient-level observations come from published pedigrees and case reports.

Landmark source

Hinson et al., New England Journal of Medicine, published 22 February 2007, established recessive BCS1L variants as causal and performed human cellular functional studies (PMID 17314340; DOI/URL: https://doi.org/10.1056/NEJMoa055262). The study describes congenital, variably severe sensorineural hearing loss and childhood-recognized pili torti. (OpenTargets Search: Bjornstad syndrome-BCS1L, hinson2007missensemutationsin pages 1-2)

2. Etiology and risk architecture

The primary cause is genetic: two clinically significant germline BCS1L alleles in trans. BCS1L is nuclear encoded; Björnstad syndrome is not caused by an mtDNA variant. In consanguineous families, homozygous alleles are more likely, but consanguinity is not required. Examples include a homozygous p.Tyr301Asn pedigree and compound-heterozygous p.Asp217His/p.Arg224His disease. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)

For two heterozygous carrier parents, the expected risk per pregnancy is 25% affected, 50% carrier, and 25% unaffected/non-carrier. Published observations support variable expressivity, especially in hearing severity, but robust penetrance estimates are unavailable. No validated susceptibility loci, modifier genes, protective alleles, anticipation, or disease-relevant epigenetic mechanism were identified.

No environmental toxin, lifestyle exposure, infectious agent, or gene–environment interaction is established as a cause. Avoiding traction, heat, bleaching, and harsh chemical treatment may reduce breakage of already fragile hair, but it does not modify the mitochondrial lesion. Diet, smoking, alcohol, exercise, vaccination, and occupational exposure have no demonstrated effect on occurrence of the Mendelian disorder.

3. Phenotypes and temporal development

Core phenotype

  1. Sensorineural hearing impairment is usually congenital or recognized in infancy/early childhood, is generally bilateral and cochlear, and ranges from moderate to profound. It may progress. In one five-person Pakistani pedigree, thresholds were 70–110 dB; children had moderate-to-severe loss and adults severe-to-profound loss. Suggested terms include HP:0000407 Sensorineural hearing impairment, bilateral hearing impairment, congenital hearing impairment, and progressive hearing impairment. (siddiqi2013novelmutationin pages 1-2)
  2. Pili torti is a physical hair-shaft sign: shafts are flattened and rotated approximately 180° at irregular intervals, causing coarse, dull, brittle hair, hypotrichosis, or nonscarring alopecia. In one pedigree scalp hair and eyelashes began falling out at 2–3 months. Suggested terms are Pili torti, brittle hair, sparse scalp hair/hypotrichosis, and nonscarring alopecia. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)

Published cases demonstrate variability. A six-year-old had hair shedding and hearing loss by age one, profound cochlear loss, intellectual disability, and normal eyebrows, eyelashes, skin, nails, and testes. By contrast, the five-person pedigree included eyelash loss, anhidrosis, light eyes, short stature, and lean habitus in affected males, with normal teeth, nails, palms, and soles. These secondary features should be coded as case-level observations, not mandatory syndrome criteria. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)

Course and quality of life

The disorder is chronic and lifelong. Hearing impairment can substantially affect speech and language acquisition, education, social participation, and employment, particularly when intervention is delayed. Hair fragility is not generally medically dangerous but may produce cosmetic and psychosocial burden. No Björnstad-specific EQ-5D, SF-36, PROMIS, or longitudinal natural-history dataset was found.

There are no validated clinical stages or remission pattern. Hair density and hearing severity may vary, but spontaneous molecular remission is not expected. Infancy and early childhood constitute the critical intervention window for hearing habilitation and language development.

4. Genetics and pathogenic variants

BCS1L encodes a 419-amino-acid, inner-mitochondrial-membrane AAA-family ATPase/chaperone. Its architecture comprises an N-terminal mitochondrial targeting/transmembrane region, a Bcs1-specific middle domain, and a C-terminal AAA ATPase domain. (hinson2007missensemutationsin pages 1-2, zhan2024conformationsofbcs1l pages 2-3, blazquez2013mitochondrialcomplexiii pages 7-10)

Representative classic-associated variants include:

  • c.901T>A, p.Tyr301Asn, homozygous, exon 8/AAA domain. It segregated with disease in five relatives, was absent from 137 Pakistani controls and 1000 Genomes, and was computationally predicted deleterious. Published 31 October 2013; DOI: https://doi.org/10.1038/jhg.2013.101. (siddiqi2013novelmutationin pages 1-2)
  • c.649G>C, p.Asp217His and c.671G>A, p.Arg224His, compound heterozygous; each unaffected parent carried one allele. The former was novel in the 2021 report; the latter was previously observed at very low population frequency. DOI: https://doi.org/10.1111/pde.14768. (trinh2021alopeciaandhearing pages 1-2)

Broader-spectrum examples must not automatically be annotated as classic Björnstad alleles: homozygous c.142A>G, p.Met48Val caused deafness with Fanconi-type tubulopathy, growth retardation, microcephaly, and liver dysfunction; homozygous c.712A>G, p.Ser328Gly was associated with severe neonatal multisystem disease; and c.548G>A, p.Arg183His plus c.1061_1062insCTA, p.Gly354delinsGlyTyr occurred with complex III deficiency and neurologic, renal, hepatic, and metabolic manifestations. (qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2)

Published labels such as “novel,” “predicted pathogenic,” or “disease-associated” should not substitute for current ACMG/AMP assessment. A production database should retrieve current ClinVar assertions, gnomAD allele counts, transcript version, segregation, and functional evidence for each exact allele. The retrieved literature did not provide reliable current frequencies for every variant. No recurrent chromosomal abnormality, pathogenic aneuploidy, somatic origin, methylation signature, or repeat expansion is implicated.

5–6. Pathophysiology and current mechanistic understanding

Ordered causal chain

  1. Biallelic BCS1L dysfunction leads to impaired function or organization of the mitochondrial inner-membrane BCS1L ATPase complex.
  2. Impaired BCS1L leads to defective ATP-dependent translocation of the folded, Fe–S-cluster-containing UQCRFS1/Rieske ISP extrinsic domain from the matrix side across the inner membrane.
  3. Defective translocation/insertion results in accumulation of Rieske-deficient complex III precomplexes and impaired final maturation of dimeric complex III.
  4. Defective complex III assembly leads to reduced ubiquinol-to-cytochrome-c electron transport, altered proton translocation, impaired respirasome/oxidative-phosphorylation performance, and altered reactive-oxygen-species handling. (hinson2007missensemutationsin pages 1-2, tegelberg2017respiratorychaincomplex pages 1-2, cunatova2024pathologicalvariantsin pages 1-4)
  5. Energetic/redox stress is inferred to cause selective dysfunction or injury of cochlear sensory cells and hair-follicle cells; direct human cell-type-resolved proof remains incomplete.
  6. Cochlear dysfunction results in sensorineural hearing loss, while hair-follicle/hair-shaft dysfunction results in pili torti, fragility, and hypotrichosis.
  7. Branch: more disruptive alleles—especially those affecting ATP binding/hydrolysis—can lead to systemic respiratory-chain failure, causing lactic acidosis, renal tubulopathy, hepatopathy, encephalopathy, cardiomyopathy, or GRACILE syndrome rather than classic restricted Björnstad syndrome. (hinson2007missensemutationsin pages 9-10, cunatova2024pathologicalvariantsin pages 5-7)

Hinson et al. found disrupted complex III/respirasome assembly, reduced electron-transport activity, and increased ROS in variant-bearing cells. Björnstad-associated substitutions tended to map to externally exposed residues implicated in protein interactions, whereas severe alleles more directly affected ATP binding/hydrolysis. Complex I-derived superoxide was higher in severe complex-III mutations than in Björnstad mutations (P=0.04), supporting—but not proving—the proposed severity gradient. (hinson2007missensemutationsin pages 1-2, hinson2007missensemutationsin pages 9-10)

2024 structural update

Zhan et al., Nature Communications, accepted 20 May 2024, used cryo-EM during active ATP hydrolysis. Their abstract states: “The human AAA-ATPase Bcs1L translocates the fully assembled Rieske iron-sulfur protein (ISP) precursor across the mitochondrial inner membrane, enabling respiratory Complex III assembly.” The subunits moved directly and uniformly between ATP- and ADP-associated conformations without detectable mixed nucleotide intermediates, favoring a concerted, rather than sequential staircase/threading, mechanism. Folded ISP could be trapped in the all-ADP state and was proposed to be released in the apo state; purified ISP stimulated ATPase activity by approximately 50%. DOI/URL: https://doi.org/10.1038/s41467-024-49029-y. (zhan2024conformationsofbcs1l pages 1-2, zhan2024conformationsofbcs1l pages 2-3)

The 2024 complex III review states: “Mitochondrial disorders are a group of clinically and biochemically heterogeneous genetic diseases within the group of inborn errors of metabolism.” It places BCS1L at the final UQCRFS1 insertion/activation step and identifies BCS1L variants as the most frequent among nuclear causes of complex III deficiency. Čunátová and Fernández-Vizarra, accepted 2 May 2024, published July 2024; DOI/URL: https://doi.org/10.1002/jimd.12751. (cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7)

Suggested ontology annotations

  • GO biological process: mitochondrial respiratory-chain complex III assembly; protein translocation across mitochondrial inner membrane; ubiquinol-to-cytochrome-c electron transport; oxidative phosphorylation; proton transmembrane transport; cellular response to oxidative stress.
  • GO cellular component: GO:0005743 mitochondrial inner membrane; mitochondrial matrix; GO:0005750 mitochondrial respiratory-chain complex III; GO:0070469 respirasome.
  • Cell Ontology: auditory hair cell; inner hair cell; outer hair cell; hair-follicle keratinocyte. These cell assignments are biologically plausible but not all are directly established by single-cell analysis in patients.
  • No Björnstad-specific transcriptomic, proteomic, metabolomic, lipidomic, single-cell, spatial-transcriptomic, epigenomic, or multi-omic diagnostic signature was identified.

7. Anatomical structures affected

The principal organs/tissues are the inner ear/cochlea, especially the auditory sensory apparatus, and scalp hair follicles/hair shafts. Suggested UBERON concepts are cochlea, organ of Corti, inner ear, skin of scalp, and hair follicle. Hearing loss is generally bilateral. Hair involvement is principally scalp hair; eyebrow, eyelash, and other body-hair involvement is variable. (siddiqi2013novelmutationin pages 1-2, trinh2021alopeciaandhearing pages 1-2)

Renal tubules, liver, brain, skeletal muscle, and heart are secondary sites in broader BCS1L mitopathy, not required anatomical targets in classic Björnstad syndrome. A patient with p.Met48Val showed muscle-specific complex III deficiency absent in fibroblasts, illustrating tissue dependence of biochemical testing. (jackson2016anovelmutation pages 1-2)

8–9. Natural history, inheritance, and population

Onset is congenital to early pediatric and generally insidious rather than acute. Hearing impairment may progress; pili torti and hair fragility are usually apparent in infancy or childhood. Classic disease is lifelong and generally considered compatible with normal lifespan, whereas severe BCS1L-related disease can cause early death. (siddiqi2013novelmutationin pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10, cunatova2024pathologicalvariantsin pages 5-7)

No credible prevalence per 100,000, incidence, carrier frequency, or sex ratio was identified. Both males and females are affected, as expected for autosomal-recessive inheritance. Reports include families from multiple geographic ancestries. Consanguinity has facilitated discovery of homozygous alleles, but no classic Björnstad founder effect was established. There is no evidence of genetic anticipation. Published case counts should not be converted into prevalence because ascertainment and publication bias are severe.

10. Diagnostics

Recommended workflow

  1. Phenotype recognition: early bilateral sensorineural hearing loss plus sparse, brittle, or lusterless scalp hair.
  2. Audiology: age-appropriate pure-tone or behavioral audiometry, auditory brainstem response, otoacoustic emissions, tympanometry, and speech testing to define cochlear versus conductive/retrocochlear disease and quantify severity.
  3. Hair examination: trichoscopy followed by light or electron microscopy when needed. Pili torti is flattened hair with irregular approximately 180° twists; it is a sign, not a disease-specific test. (trinh2021alopeciaandhearing pages 1-2)
  4. Molecular confirmation: sequencing and deletion/duplication analysis of BCS1L, or a syndromic-hearing-loss/mitochondrial panel. Demonstrating two clinically significant variants in trans and parental segregation is preferred.
  5. Expanded testing: WES or WGS is useful when targeted testing is negative, the phenotype is atypical, or additional organ involvement suggests another mitochondrial diagnosis. RNA studies may help resolve splice variants, but no validated Björnstad transcriptomic assay exists.
  6. Biochemical support: lactate, liver and renal indices, respiratory-chain enzyme assays, oxygen-consumption studies, blue-native PAGE, and complex III assembly analysis may be indicated in multisystem disease or variant functional assessment. Routine spectrophotometric assays and fibroblasts can miss tissue-dependent complex III abnormalities. (tegelberg2017respiratorychaincomplex pages 1-2, jackson2016anovelmutation pages 1-2)

CMA, karyotyping, FISH, mitochondrial-genome sequencing, and repeat-expansion testing are not first-line tests for a classic phenotype unless independent features indicate them. No circulating biomarker, metabolite, pathology criterion, or imaging finding is diagnostic.

Differential diagnosis

Important alternatives include Crandall syndrome—pili torti and hearing loss with hypogonadism—Menkes disease, isolated pili torti, Netherton syndrome, ectodermal dysplasias, and acquired pili torti associated with inflammatory alopecias, malnutrition, systemic disease, or medications. Broader metabolic findings require consideration of GRACILE syndrome, other BCS1L mitopathies, and defects of other complex III assembly genes. (trinh2021alopeciaandhearing pages 1-2)

11. Outcome and prognosis

No 5- or 10-year survival statistics, disease-specific mortality rates, or validated prognostic biomarkers exist for classic Björnstad syndrome. Available literature describes it as the mildest BCS1L phenotype and generally compatible with normal lifespan. Principal morbidity is permanent hearing disability and its developmental consequences; hair fragility is lifelong but not ordinarily life-threatening. (blazquez2013mitochondrialcomplexiii pages 7-10)

Prognosis changes materially when lactic acidosis, failure to thrive, tubulopathy, hepatic dysfunction, encephalopathy, seizures, cardiomyopathy, or profound developmental abnormalities are present. Such patients occupy the broader BCS1L disease spectrum, where early mortality can occur, and should not be counseled using classic Björnstad expectations. (qurashi2022clinicalanddiagnostic pages 1-2, jackson2016anovelmutation pages 1-2, cunatova2024pathologicalvariantsin pages 5-7)

12. Treatment and real-world implementation

There is no curative or approved BCS1L-directed pharmacotherapy, gene therapy, RNA therapy, cell therapy, or precision small-molecule treatment.

  • Hearing: prompt hearing-aid fitting, serial audiology, speech/language therapy, educational accommodations, and communication support. Cochlear implantation is reasonable for severe-to-profound loss when conventional audiological criteria are met, although the retrieved evidence did not provide extractable numerical outcome data from the 2024 case series. Suggested NCIT concepts: Hearing Aid Device, Cochlear Implantation, Speech Therapy, Audiologic Rehabilitation.
  • Hair: gentle grooming, avoidance of heat/chemical trauma and traction, cosmetic camouflage, and dermatologic support. Evidence for pharmacologic hair-growth treatment is insufficient.
  • Broader disease: mitochondrial-specialist care and organ-specific management for renal, hepatic, neurologic, cardiac, nutritional, and metabolic complications.

A 2020 multisystem case used CoQ10, carnitine, and vitamins alongside seizure therapy and reported short-term clinical improvement, but this is uncontrolled anecdotal evidence from complex III deficiency—not proof of efficacy in classic Björnstad syndrome. Vitamin or “mitochondrial cocktail” therapy should therefore not be represented as established treatment. (qurashi2022clinicalanddiagnostic pages 1-2)

No Björnstad-specific ClinicalTrials.gov interventional study was identified. Pharmacogenomic recommendations, treatment-response rates, and syndrome-specific adverse-event statistics are unavailable.

13. Prevention

Primary prevention by lifestyle, vaccination, or environmental modification is not applicable to a recessive germline disorder. Clinically meaningful prevention focuses on recurrence and complications:

  • genetic counseling and confirmation of familial variants;
  • cascade carrier testing for adult relatives;
  • prenatal molecular diagnosis or PGT-M when familial pathogenic/likely pathogenic variants are known;
  • prompt newborn/infant hearing assessment in at-risk children;
  • early hearing habilitation to reduce language and educational consequences;
  • avoidance of unnecessary hair trauma to reduce breakage.

Population newborn molecular screening is not established. Vaccination, antimicrobial prophylaxis, and public-health environmental controls are not disease-specific interventions.

14–15. Other species and model organisms

No naturally occurring veterinary equivalent, breed association, zoonotic potential, or cross-species transmission is known. BCS1L orthologues are evolutionarily conserved, but Björnstad syndrome is not infectious.

Saccharomyces cerevisiae Bcs1 has been central to defining ATP-dependent insertion/translocation of folded Rieske protein and can be used for variant validation and phenotype-based drug screening. Mammalian Bcs1l knock-in/mutant mice reproduce aspects of broader complex III deficiency, hepatopathy, and tissue macrophage abnormalities. A 2017 mouse model partially phenocopied encephalomyopathic BCS1L disease, including abnormalities of microglia and Kupffer cells; it was not a validated model of the classic hair-plus-hearing syndrome. (tegelberg2017respiratorychaincomplex pages 1-2, blazquez2013mitochondrialcomplexiii pages 7-10)

No model was identified that robustly reproduces both human pili torti and progressive sensorineural hearing loss from a classic Björnstad allele. This limits preclinical evaluation of tissue-selective therapies.

Evidence assessment and key gaps

The strongest causal evidence combines recessive segregation, absence/rarity in controls, human cell functional assays, and conserved structural biology. However, the clinical evidence base remains dominated by individual cases and small consanguineous pedigrees. Frequencies of secondary phenotypes, penetrance, progression rates, quality-of-life scores, carrier frequencies, and intervention outcomes are therefore unknown rather than zero.

The central unresolved question is why partial disruption of a ubiquitous respiratory-chain assembly factor preferentially injures cochlear and hair-follicle tissues in classic disease. No validated modifier gene, protective variant, environmental interaction, epigenetic signature, omics biomarker, prognostic model, classic animal model, or disease-modifying trial was found. The 2024 structural studies clarify the normal ATP-driven machine and create a framework for interpreting variants, but they do not yet supply a therapy. (hinson2007missensemutationsin pages 9-10, trinh2021alopeciaandhearing pages 2-2, zhan2024conformationsofbcs1l pages 1-2, cunatova2024pathologicalvariantsin pages 5-7)

Selected primary and authoritative references

  1. Hinson JT et al. Missense mutations in the BCS1L gene as a cause of the Björnstad syndrome. N Engl J Med. 2007;356:809–819. Published 22 February 2007. PMID: 17314340. https://doi.org/10.1056/NEJMoa055262. (hinson2007missensemutationsin pages 1-2)
  2. Siddiqi S et al. Novel mutation in AAA domain of BCS1L causing Bjornstad syndrome. J Hum Genet. 2013;58:819–821. Published 31 October 2013. https://doi.org/10.1038/jhg.2013.101. (siddiqi2013novelmutationin pages 1-2)
  3. Trinh NB et al. Alopecia and hearing loss in a boy. Pediatr Dermatol. 2021;38:e61–e62. Published November 2021. https://doi.org/10.1111/pde.14768. (trinh2021alopeciaandhearing pages 1-2)
  4. Tegelberg S et al. Respiratory chain complex III deficiency due to mutated BCS1L: a novel phenotype with encephalomyopathy, partially phenocopied in a Bcs1l mutant mouse model. Orphanet J Rare Dis. 2017;12:73. https://doi.org/10.1186/s13023-017-0624-2. (tegelberg2017respiratorychaincomplex pages 1-2)
  5. Zhan J et al. Conformations of Bcs1L undergoing ATP hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate. Nat Commun. 2024;15. Published May 2024. https://doi.org/10.1038/s41467-024-49029-y. (zhan2024conformationsofbcs1l pages 1-2)
  6. Čunátová K, Fernández-Vizarra E. Pathological variants in nuclear genes causing mitochondrial complex III deficiency: An update. J Inherit Metab Dis. 2024;47:1278–1291. Published July 2024. https://doi.org/10.1002/jimd.12751. (cunatova2024pathologicalvariantsin pages 1-4, cunatova2024pathologicalvariantsin pages 5-7)

References

  1. (OpenTargets Search: Bjornstad syndrome-BCS1L): Open Targets Query (Bjornstad syndrome-BCS1L, 10 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  2. (hinson2007missensemutationsin pages 1-2): J. Travis Hinson, Valeria R. Fantin, Jost Schönberger, Noralv Breivik, Geir Siem, Barbara McDonough, Pankaj Sharma, Ivan Keogh, Ricardo Godinho, Felipe Santos, Alfonso Esparza, Yamileth Nicolau, Edgar Selvaag, Bruce H. Cohen, Charles L. Hoppel, Lisbeth Tranebjærg, Roland D. Eavey, J.G. Seidman, and Christine E. Seidman. Missense mutations in the bcs1l gene as a cause of the björnstad syndrome. The New England journal of medicine, 356 8:809-19, Feb 2007. URL: https://doi.org/10.1056/nejmoa055262, doi:10.1056/nejmoa055262. This article has 253 citations and is from a highest quality peer-reviewed journal.

  3. (tegelberg2017respiratorychaincomplex pages 1-2): Saara Tegelberg, Nikica Tomašić, Jukka Kallijärvi, Janne Purhonen, Eskil Elmér, Eva Lindberg, David Gisselsson Nord, Maria Soller, Nicole Lesko, Anna Wedell, Helene Bruhn, Christoph Freyer, Henrik Stranneheim, Rolf Wibom, Inger Nennesmo, Anna Wredenberg, Erik A. Eklund, and Vineta Fellman. Respiratory chain complex iii deficiency due to mutated bcs1l: a novel phenotype with encephalomyopathy, partially phenocopied in a bcs1l mutant mouse model. Orphanet Journal of Rare Diseases, Apr 2017. URL: https://doi.org/10.1186/s13023-017-0624-2, doi:10.1186/s13023-017-0624-2. This article has 32 citations and is from a peer-reviewed journal.

  4. (zhan2024conformationsofbcs1l pages 1-2): Jingyu Zhan, Allison R. Zeher, Rick Huang, Wai Kwan Tang, Lisa M. Jenkins, and Di Xia. Conformations of bcs1l undergoing atp hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate. Nature Communications, May 2024. URL: https://doi.org/10.1038/s41467-024-49029-y, doi:10.1038/s41467-024-49029-y. This article has 14 citations and is from a highest quality peer-reviewed journal.

  5. (cunatova2024pathologicalvariantsin pages 1-4): Kristýna Čunátová and Erika Fernández‐Vizarra. Pathological variants in nuclear genes causing mitochondrial complex iii deficiency: an update. Journal of Inherited Metabolic Disease, 47:1278-1291, Jul 2024. URL: https://doi.org/10.1002/jimd.12751, doi:10.1002/jimd.12751. This article has 19 citations and is from a peer-reviewed journal.

  6. (cunatova2024pathologicalvariantsin pages 5-7): Kristýna Čunátová and Erika Fernández‐Vizarra. Pathological variants in nuclear genes causing mitochondrial complex iii deficiency: an update. Journal of Inherited Metabolic Disease, 47:1278-1291, Jul 2024. URL: https://doi.org/10.1002/jimd.12751, doi:10.1002/jimd.12751. This article has 19 citations and is from a peer-reviewed journal.

  7. (blazquez2013mitochondrialcomplexiii pages 7-10): Alberto Blázquez, Lorena Marín-Buera, María Morán, Alberto García-Bartolomé, Joaquín Arenas, Miguel A. Martín, and Cristina Ugalde. Mitochondrial complex iii deficiency of nuclear origin. ArXiv, pages 219-238, Sep 2013. URL: https://doi.org/10.1007/978-1-4614-3722-2_14, doi:10.1007/978-1-4614-3722-2_14. This article has 0 citations.

  8. (siddiqi2013novelmutationin pages 1-2): Saima Siddiqi, Saadat Siddiq, Atika Mansoor, Jaap Oostrik, Nafees Ahmad, Syed Ali Raza Kazmi, Hannie Kremer, Raheel Qamar, and Margit Schraders. Novel mutation in aaa domain of bcs1l causing bjornstad syndrome. Journal of Human Genetics, 58:819-821, Oct 2013. URL: https://doi.org/10.1038/jhg.2013.101, doi:10.1038/jhg.2013.101. This article has 26 citations and is from a peer-reviewed journal.

  9. (trinh2021alopeciaandhearing pages 1-2): Ngo Binh Trinh, Hoang Anh Vu, Anh Khoa Pham, Waleed Adawi, Stephanie A. Castillo, and Linh Ngoc Tuong Tran. Alopecia and hearing loss in a boy. Pediatric Dermatology, Nov 2021. URL: https://doi.org/10.1111/pde.14768, doi:10.1111/pde.14768. This article has 1 citations and is from a peer-reviewed journal.

  10. (zhan2024conformationsofbcs1l pages 2-3): Jingyu Zhan, Allison R. Zeher, Rick Huang, Wai Kwan Tang, Lisa M. Jenkins, and Di Xia. Conformations of bcs1l undergoing atp hydrolysis suggest a concerted translocation mechanism for folded iron-sulfur protein substrate. Nature Communications, May 2024. URL: https://doi.org/10.1038/s41467-024-49029-y, doi:10.1038/s41467-024-49029-y. This article has 14 citations and is from a highest quality peer-reviewed journal.

  11. (qurashi2022clinicalanddiagnostic pages 1-2): Mansour Al Qurashi, Ahmed Mustafa, Syed Sameer Aga, Abrar Ahmad, Abdellatif El-Farra, Aiman Shawli, Mohammed Al Hindi, and Mohammed Hasosah. Clinical and diagnostic characteristics of complex iii mitopathy due to novel bcs1l gene mutation in a saudi patient. BMC Medical Genomics, Mar 2022. URL: https://doi.org/10.1186/s12920-022-01210-2, doi:10.1186/s12920-022-01210-2. This article has 3 citations and is from a peer-reviewed journal.

  12. (jackson2016anovelmutation pages 1-2): C. B. Jackson, M. F. Bauer, A. Schaller, U. Kotzaeridou, A. Ferrarini, D. Hahn, H. Chehade, F. Barbey, C. Tran, S. Gallati, A. Haeberli, S. Eggimann, L. Bonafé, and J-M. Nuoffer. A novel mutation in bcs1l associated with deafness, tubulopathy, growth retardation and microcephaly. European Journal of Pediatrics, 175:517-525, Apr 2016. URL: https://doi.org/10.1007/s00431-015-2661-y, doi:10.1007/s00431-015-2661-y. This article has 24 citations and is from a peer-reviewed journal.

  13. (hinson2007missensemutationsin pages 9-10): J. Travis Hinson, Valeria R. Fantin, Jost Schönberger, Noralv Breivik, Geir Siem, Barbara McDonough, Pankaj Sharma, Ivan Keogh, Ricardo Godinho, Felipe Santos, Alfonso Esparza, Yamileth Nicolau, Edgar Selvaag, Bruce H. Cohen, Charles L. Hoppel, Lisbeth Tranebjærg, Roland D. Eavey, J.G. Seidman, and Christine E. Seidman. Missense mutations in the bcs1l gene as a cause of the björnstad syndrome. The New England journal of medicine, 356 8:809-19, Feb 2007. URL: https://doi.org/10.1056/nejmoa055262, doi:10.1056/nejmoa055262. This article has 253 citations and is from a highest quality peer-reviewed journal.

  14. (trinh2021alopeciaandhearing pages 2-2): Ngo Binh Trinh, Hoang Anh Vu, Anh Khoa Pham, Waleed Adawi, Stephanie A. Castillo, and Linh Ngoc Tuong Tran. Alopecia and hearing loss in a boy. Pediatric Dermatology, Nov 2021. URL: https://doi.org/10.1111/pde.14768, doi:10.1111/pde.14768. This article has 1 citations and is from a peer-reviewed journal.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 10
Resolved 10
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 10
On topic 2
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 5
Resolved 3
Unresolved (possible confabulation) 0
Obsolete 2
Unverifiable 0

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

  • GO:0005750 (obsolete mitochondrial respiratory chain complex III) (2 mentions) - replaced by GO:0045275
  • GO:0070469 (obsolete respirasome) (2 mentions) - replaced by GO:0098803

3 of 5 terms resolved to a current term; the rest could not be looked up either way.